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Abstract
The prevalence of severe to profound bilateral congenital hearing loss is estimated at 1 in
1000 births, at least half of which can be attributed to a genetic cause. To date, mutations in
at least 67 genes have been associated with hearing loss. Discovery of these genes has
revealed fundamental processes within the ear, and enabled diagnosis and implementation of
genetic counseling in affected patients. As a part of the continuing effort to study genes
important for hearing and deafness, a novel cochlear transcript with predominantly fetal
expression containing a single tetramerization domain (PFET1, HUGO-approved symbol
KCTD12) was identified from the Morton fetal cochlear cDNA library. KCTD12/Kctdl]2 is an
evolutionarily conserved intronless gene encoding a 6 kb transcript in human and three
transcripts of approximately 4, 4.5 and 6 kb in mouse. The protein, pfetin, is predicted to
contain a voltage-gated potassium channel tetramerization (T1) domain. This thesis reports
characterization of this novel human gene and its encoded protein pfetin in relation to its role
in auditory function. Experimental data from tissue and cellular expression profiling, and
genetic and functional analyses suggests KCTD12 and its orthologs playing a crucial role in
the developmental of the auditory sense organ.
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CHAPTER 1
1
Hearing loss is the most common sensory disorder in the human population with the
incidence of congenital hearing loss estimated at 1 in 1000 births (Morton 1991). It is
estimated that 50% to 75% of all childhood deafness is due to hereditary causes (Gorlin 1995).
The remainder is due to environmental factors including acoustic trauma, ototoxic drugs (e.g.,
aminoglycosides), bacterial and viral infections. Of the hearing disorders with a genetic
contribution, roughly 70% are classified as nonsyndromic and 30% as syndromic, depending
on the presence or absence of other clinical features (http://webhost.ua.ac.be/hhh/). To date,
mutations in at least 67 genes have been associated with hearing loss. Discovery of these
genes has revealed fundamental processes within the ear, and enabled diagnosis and
implementation of more accurate genetic counseling for families and affected patients.
The auditory apparatus consists of three major compartments, the external, middle and
inner ear. The external ear consists of the auricle and the external auditory canal. It is bounded
at the external-middle ear junction by the tympanic membrane. The middle ear is an air-filled
cavity containing a chain of three ossicles (malleus, incus, stapes). The inner ear resides in the
temporal bone of the skull, and is a complex membranous labyrinth filled with endolymph
housed inside a perilymph-filled bony labyrinth. The snail-like portion of this labyrinth is
called the cochlea, the auditory sense organ. It resides in the inner ear along with the vestibule.
The human cochlea detects sound frequencies between 20 Hz and 20 kHz and the vestibule
(saccule, utricle, three semicircular canals) responds to linear and angular accelerations. The
cochlea and the vestibule both derive embryologically from the otic placode (Fekete 1996)
and share several structural and functional features.
Briefly, the mammalian hearing process functions as follows. Sound waves travel
through the external ear canal to the tympanic membrane (TM) where sound pressure sets the
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TM into vibration. The ossicular chain, attached at one end to the TM, contacts the cochlea
via the oval window. Vibration creates a traveling wave in the endolymph down the length of
the cochlea, and the traveling wave sets into motion the basilar membrane (on which rests a
cellular layer known as the organ of Corti lined with auditory hair cells), inducing movement
of these hair cells relative to the tectorial membrane. Deflection of the hair cells leads to their
depolarization, triggering neurotransmitter release, and creating an action potential traveling
along the auditory nerve to the brain which encodes different characteristics of the sound
stimulus including intensity, time course, and frequency.
Genes Involved in Hearing Disorders
Gene mutations have been found affecting almost every part of the auditory system
from the shape of the ear lobe, to the middle ear and the auditory neurons in the brain.
However, many encoded protein of genes responsible for deafness have been found to be
expressed in the cochlea. The cochlea is a most intricate and complex organ consisting of
dozens of cell types and specialized regions required for normal auditory function. Therefore,
genes underlying the molecular development, structure, function and maintenance of these
cell types and regions are crucial to the hearing process. As mentioned previously, mutations
in at least 67 genes have been identified to show association with hearing loss. These genes
encode a wide variety of proteins, including gap junctions, ion channels, extracellular matrix
components and transcription factors.
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Hair Cell Organization and Function
One of the most important structures in the cochlea is the auditory hair cells. These
hair cells are highly organized and convert mechanical vibration into nerve impulses, and
require precise structural maintenance for proper function. Mouse mutant studies have been
instrumental in identifying a number of deafness-associated genes that are required for the
proper organization and maintenance of hair cell stereocilia such as Myo7a, Myo6, Cdh23,
Pcdh15, Itga8, Espn and Tmie. Most of the human orthologs when mutated result in hearing
disorders: MY07A for DFNB2, DFNA11 and USH1B (Liu et al. 1997); MY015A for DFNB3
(Wang et al. 1998); CDH23 for both DFNB12 and USH1D (Bolz et al. 2001); PCDH15 for
USH1F (Ahmed et al. 2001); ESPN for DFNB36 (Naz et al. 2004); and TMIE for DFNB6
(Naz et al. 2002). In addition, mutation in MY06 results in the disorganization and fusion of
stereocilia and accounts for the nonsyndromic autosomal dominant hearing loss in an Italian
family (Melchionda et al. 2001). A defect in harmonin, a PDZ domain-containing protein
expressed in the inner ear sensory hair cells, underlies USH1C (Verpy et al. 2000) and defects
in whirlin a PDZ domain molecule involved in stereocilia elongation, cause deafness in the
whirler mouse and families with DFNB31 (Mburu et al. 2003).
Extracellldar Matrix
The extracellular matrix (ECM) is a complex structural entity surrounding and
supporting cells that are found within mammalian tissues. The ECM is composed of three
major classes of biomolecules: structural proteins like collagen and elastin; specialized
proteins such as fibrillin, fibronectin, and laminin; and proteoglycans.
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Collagens are crucial for the structural integrity of many organ systems including the
inner ear. Several collagens responsible for deafness include COL4A5, COL4A3 and COL4A4
for both X-linked and autosomal forms of Alport syndrome; COLIA] and COLIA2 for
osteogenesis imperfecta (OI); COL2AJ for Stickler syndrome type I (STLI1); COLIIA2 for
Stickler syndrome type II (STL2) and DFNA13; COLllAJ for Stickler syndrome type III
(STL3) (reviewed in Resendes et al. 2001 and Smith et al. 2005). Mutations in COL9A3 have
recently been identified in patients with nonsyndromic hearing impairment with moderate
progressive bilateral sensorineural hearing loss in all frequencies (Asamura et al. 2005). Other
extracellular matrix proteins like usherin that is responsible for Usher syndrome type 2A
(USH2A) (Eudy et al. 1998) contain both laminin epidermal growth factor and fibronectin
type III motifs, which are most commonly observed in proteins comprising components of the
basal lamina and extracellular matrixes and in cell adhesion molecules. The tectorial
membrane is also an extracellular matrix of the inner ear that contacts the stereocilia bundles
of specialized sensory hair cells. Mutations in TECTA causing defects in the membrane are
etiologic for hearing disorders DFNA8 and DFNA12 (Verhoeven et al. 1998) and DFNB21
(Mustapha et al. 1999). The cause of DFNA9 is mutations in COCH (Robertson et al. 1998)
which encodes a secreted protein that becomes part of the extracellular matrix. The mutant
form of the protein leads to the loss of cells in the spiral ligament and limbus and
accumulation of acidophilic deposits in the nerve channels and supporting tissues of the organ
of Corti.
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Ion Homeostasis
For proper auditory signal transduction, it is critical to maintain ion homeostasis,
especially regarding the high potassium concentration in endolymph. Potassium recycling
begins with an efflux of potassium from the outer hair cells through the potassium channel.
Ions migrate to the stria vascularis through gap junctions between supporting cells and are
finally pumped back into the endolymph.
Potassium channels KCNQ4, KCNQI, and KCNE1 have all been shown to play
fundamental roles in the potassium recycling pathway. Mutations in these genes lead to the
hearing disorders DFNA2, Jervell and Lange-Nielsen syndrome (loci and 2) (Schulze-Bahr
et al. 1997, Neyroud et al. 1997). Mutations in an anion transporter protein like pendrin,
encoded by SLC(26A4, are postulated to disrupt transport of negatively charged particles, thus
upsetting fluid balance in the inner ear, and causing Pendred syndrome and DFNB4 (Li et al.
1998).
Gap junction subunits are called connexins and four connexins have been implicated
in at least six types of both dominant and recessive nonsyndromic hearing loss, and they are
connexin 26 (JB2), connexin 31 (GJB3), connexin 30 (GJB6), and connexin 43 (GJA1).
GJB2 alone is estimated to account for 50% or more of recessive congenital nonsyndromic
hearing loss in some populations (Rabionet et al. 2000). In addition to ion recycling, ion
concentration mnust be strictly maintained within the two separate compartments of cochlea,
one containing perilymph and the other endolymph. Tight junctions in the cochlea are thought
to compartmentalize endolymph by controlling the permeability of the paracellular pathway.
Mutations in the tight junction gene CLDN14 may cause loss of endolymphatic potential
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leading to degeneration of cochlear hair cells, and is etiologic in the autosomal recessive
hearing loss DFNB20 (Wilcox et al. 2001).
Transcription Factors
Transcription factors regulate the spatio-temporal expression of thousands of genes
and the control of cellular proliferation, differentiation, and regulation of cellular function to
ensure proper development and functioning of an organism, and the inner ear is no exception.
Four transcription factor genes have been identified (POU3F4, POU4F3, EYA4, and
TFCP2L3) to be etiologic for the nonsyndromic hearing disorders DFN3, DFNA15, DFNA10
and DFNA28, respectively (de Kok et al. 1995, Vahava et al. 1998, Wayne et al. 2001, Peters
et al. 2002).
POU3F4 is a member of a larger family of genes called POU domain genes, which
play a role in determining cell types in the central nervous system during early development
and are likely to be involved in the development of the middle and inner ear. Mutations in or
near POU3F4 probably lead to insufficiency of POU3F4 protein, thus disrupting the normal
development of structures in the middle and inner ear and leading to hearing loss (de Kok et al.
1995). POU4F3, a class IV POU domain transcription factor, has a central function in the
development of all hair cells in the human and mouse inner ear sensory epithelia. Mutations in
POU4F3 affect protein stability, localization, and transcriptional activity (Hertzano et al.
2004).
Mutations in EYA4 lead to production of abnormal EYA4 protein, lacking some or all
of the Eya domain and thus impairing interactions with other proteins. Impaired protein
interactions probably disrupt control of gene activities that are important for the development
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of the inner ear and maintenance of normal hearing (Wayne et al. 2001). Transcription factor
TFCP2L3 was shown to be highly expressed in epithelial cells lining the cochlear duct. The
predicted translation product of TFCP2L3 has sequence similarity to a group of proteins
comprising the transcription factor cellular promoter 2 (TFCP2) family. However, its exact
function remains to be elucidated (Peter et al. 2002).
Often times, transcription factors work in synchrony during the development and
maintenance of mammalian inner ear (Corey and Breakefield 1994, Cantos et al. 2000), an
example being the interactions between MITF, PAX3, and SOX10. Mutations in these genes
result in the various subtypes of Waardenburg syndrome: PAX3 (Waardenburg syndrome
types I, III and craniofacial-deafness-hand syndrome), MITF (Waardenburg syndrome type
11), and SOXlO 0 (Waardenburg syndrome type IV). It has been shown that SOXlO 0 and PAX3
synergistically regulate MITF expression in transfection assays and mutant SOX10 and PAX3
proteins failed to bind to the MITF promoter region to commence induction (Bondurand et al.
2000).
Modifiers
In addition to genes that directly causing hearing loss, there also exist modifier genes
that can contribute to hearing disorders through their influence on the expression or function
of other genes. Notable examples include tub (tubby) and moth], dwf and mdfw in mice and
DFNB26 and DRNM in humans. Tub encodes a transcription factor with expression in the
outer and inner hair cells and the spiral ganglion cells. Moth], a modifier of tubby hearing,
can either worsen or prevent the hearing impairment in tubby, depending on the type of moth]
allele and on whether one or both copies of the allele are present (Ikeda et al. 1999). Dfvv
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encodes an ATPase pump that is necessary for maintenance of low cytosolic calcium ions
(Kozel et al. 1998; Street et al. 1998). Mdfw as a modifier of dfw (deaf wobbler) can protect
dw, heterozygotes from hearing loss with one allele and is permissive of hearing loss with the
other (Noben-Trauth et al. 1997). In the autosomal recessive, nonsyndromic sensorineural
hearing loss DFNB26, a dominant modifier gene (DFNM1) has been mapped to lq24 and is
thought to suppress deafness in individuals with DFNB26 (Riazuddin et al. 1999).
Approaches to Gene Discovery and Characterization in the Auditory System
The traditional method for identification of genes involved in deafness begins by
collection of DNAs from kindreds segregating a hearing impairment. It is then followed by
genetic linkage analysis to identify the region of genome in which a gene involved in hearing
is likely to reside. Once the region is discovered, positional cloning is then performed. When
successful, it can reveal the identity of the gene involved in the deafness. This process has
been very successful in identifying a number of human deafness genes such as NDP, TCOF1,
DDP, SLC26A4, USH2A and DFNA5 (Morton 2002). However due to the complex genetic
nature of deafness, linkage analysis is a less than optimum method in gene discovery efforts
for hearing disorders. Successful use of genetic linkage for mapping hearing disorders in
autosomal recessive nonsyndromic loci has been fruitful largely in consanguineous kindreds
or populations in which there has been limited admixture. Even in families in which a
heritable hearing disorder is successfully mapped, there may be insufficient numbers of
recombination events to narrow a chromosomal interval, resulting in a candidate region in the
megabase scale.
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A complementary method to the genetic linkage analysis for gene identification is one
that utilizes tissues or organ-specific cDNA libraries to provide candidate genes (Hedrick et
al. 1984, Jones et al. 1989, Gurish et al 1992). Presently, cochlear libraries are available for
human, mouse, rat and chicken. These libraries have provided valuable tools for gene
discovery in hearing and deafness. Almost 15,000 human (Morton fetal cochlear cDNA
library) and 1,600 mouse (Soares mouse NMIE cDNA library) inner ear ESTs are currently
available in the GenBank (http://www.ncbi.nlm.nih.gov/gquery/gquery.fcgi). ESTs from the
human cochlear cDNA clones have already elucidated thousands of potential positional
candidate genes for hearing disorders. Some of the human ESTs are genes already known to
be involved in deafness: COL4A5 (Alport syndrome), EDNRB (Waardenburg syndrome, type
IV), EYA1A (130R syndrome), GJB2 (DFNB1 and DFNA3), GJB6 (DFNA3), KVLQT1
(Jervelle and L.ange-Nielsen syndrome), and MY06 (DFNA22). Several genes preferentially
expressed in the cochlea, namely COCH (Robertson et al. 1997), OTOR (Roberton et al. 2000)
and KCTD12/P-FET (Resendes and Kuo, 2004) have been identified from the human fetal
cochlea cDNA library. COCH was further shown to be responsible for the sensorineural
deafness and vestibular disorder, DFNA9 (Robertson et al. 1998). Using a similar approach, a
number of genes implicated in murine auditory function have been identified from mouse
inner ear transcripts, such as Otog, Ocn95, Fdp (mouse homolog of OTOR), Strc and Ushlc,
and (Morton 2002). The human ortholog of Strc was found to be etiologic in DFNB 16 (Verpy
et al. 2001) and mutations found in the human ortholog of Ushlc underlie USHIC and
DFNB 18 (Ahnmed et al. 2002).
In addition to inner ear cDNA libraries, microarray technology offers a rapid and
efficient way of identifying new deafness genes. It is a highly sensitive assay that requires
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very little starting material. It was instrumental in the identification of CRYM (Abe et al. 2003)
and COL9A3 (Asamura et al. 2005), which were then studied as candidate genes for
nonsyndromic deafness. With the completion of the DNA sequence of the human and mouse
genomes, the sequence can be used to determine the expression pattern of thousands of genes
from the inner ear. Cross-tissue comparisons facilitate identification of genes that are
preferentially expressed in the inner ear. Microdissection and subtraction between data sets
can help identify cell-type specific and structural-specific genes important for the function of
the inner ear and expedite identification of genes that interact with deafness genes (Corey and
Chen, 2002).
Model Organisms for Hearing and Deafness
Genes discussed in the previous section constitute just a fraction of what is involved in
the process of hearing. Animal models have been invaluable in understanding how mutations
or changes in these genes affect the function and development of the ear. Model organisms,
genetically altered or pharmacologically treated, have been employed in the study of human
diseases for many years. Animal models have made available a wide variety of studies
including gene expression during development, anatomical and physiological experimentation,
and various kinds of genetic manipulation that are not possible or ethical with human subjects.
These have helped elucidate important questions such as whether candidate genes actually
cause disease and by what mechanisms a gene mutation underlies a disorder.
Many considerations are taken into account when choosing an animal model, such as a
researcher's familiarity with and accessibility to the animal. In addition, the time required to
produce an animal model is critical, which is determined partly by the animal's generation
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time, and in part by the ease of disease gene modification (lower eukaryotes being faster than
higher eukaryotes). The potential resemblance of the phenotype observed in the animal model
compared to that in human is an important criterion; this choice is dependent upon the disease
gene under study and the affected organ. In general, the lowest eukaryote containing an
ortholog of the human disease gene and the organ system is the preferred model organism.
Mouse Models
The mouse is a great model for studying human genetic deafness and genes essential
for the auditory system because the anatomy, function, and hereditary abnormalities of the
mouse ear have been shown to be highly similar to that of humans (Probst and Camper 1997).
There are two general approaches to the utilization of mouse models in the analysis of human
disease, one being the disease-driven directed genetic approach and the other mutagenesis-
driven non-directed approach. In the direct approach, the disease-causing genes are already
identified and the mutation characterized in the human population. Then, the mouse ortholog
is identified and manipulation performed for functional gene alteration. Specifically, genetic
modification may be introduced via transgenic animals where multiple copies of a foreign
mutant gene were are inserted into its genome, or gene targeting where one or both normal
alleles of the animal's ortholog are mutated typically via homologous recombination. In the
non-directed approach, the process begins with the genetic modification and phenotype
characterization in the mice followed by genetic and molecular studies of the disease. This is
exemplified by chemically induced mutations via N-ethyl-N-nitrosourea (ENU) where mice
are treated with ENU and screened for hearing and balance phenotypes. There are multiple
centers performing mouse ENU mutagenesis including Harwell in the UK; Neuherberg in
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Germany; Ricken in Japan; and Brigham and Women's Hospital, The Jackson Laboratory,
Baylor College of Medicine, McLaughlin Research Institute and Oak Ridge National
Laboratory in the United States. Both spontaneous and chemically induced mutations provide
an array of naturally occurring and randomly induced mouse mutations to study. Advantages
and limitations are associated with each approach and technique (reviewed in Chapter 15 of
Current Protocols in Human Genetics, and Brown and Hardisty, 2003).
In addition to these genetically engineered and chemically induced mutations, there
are also mutations that spontaneously arise in the mice (Johnson 2001). Spontaneous
mutations have occurred naturally in large inbred populations of mice and they constitute a
large portion of the mouse mutations now being used as models for human deafness. These
mutations are identified often through behavioral abnormalities. Mice displaying
hyperactivity, head bobbing, and circling behavior typical of vestibular dysfunction are
frequently found to be deaf or hearing impaired. Other abnormalities in pigmentation and
development can be associated with a hearing deficit as well. Certain inbred strains of mice
exhibit a late-onset, progressive hearing loss, providing valuable models for the study of
human age-related hearing loss (AHL), or presbycusis. In both humans and mice, AHL occurs
earliest at high frequencies with loss of sensory hair cells from the base to the apex of the
cochlea. Thus far, three AHL loci have been mapped, Ahl3(AHL-resistant) (Nemoto et al.
2004), Ahl and Ahl2 (AHL-sensitive) (Johnson and Zheng 2002).
Deaf mouse mutants are posted on the Sanger Institute website
(http://www.sanger.ac.uk/PostGenomics/mousemutants/deaf/). This site contains a current
listing of genes or loci identified thus far known to be involved in deafness and/or balance
defects in mice with a wide array of abnormalities from the periphery to the central auditory
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system. Numerous human hearing disorders with mouse models can be found at The Jackson
Laboratory website (http://wwwjax.org/hmr/models.html). There are currently at least 22
nonsyndromic and 30 syndromic human deafness genes with corresponding mouse mutations.
Zebrafish Models
Zebrafish (Danio rerio) has become an important model system for the study of
development and function of the vertebrate inner ear. The vertebrate inner ear is a complex
system involving many sensory organs. It can be divided into two major compartments, dorsal
and ventral. The dorsal part containing the utricle macula and three cristae for the semicircular
canals is highly conserved structurally and functionally amongst all vertebrates. The ventral
part becomes more specific to each vertebrate class and contains the macular organs of the
saccule and lagena, which function in balance, audition or both. In the case of zebrafish, the
primary auditory organ is the saccule. Sound is detected through the fish's air-filled swim
bladder and transmitted via a series of bones called the Weberian ossicles connecting the
swim bladder to the sensory patch in the saccule. There are also additional auditory inputs
from the lagena and macula neglecta that are developed later during the juvenile stage (Fekete
and Wu 2002). In addition to the inner ear, zebrafish also possess another sensory organ
called the lateral line that allows for the detection of low-frequency stimuli such as water
movements.
There are several advantages to using zebrafish as a model for studying hearing.
Embryogenesis is rapid, and monitoring and manipulation of auditory organs in vivo during
development are possible. Although zebrafish do not possess the equivalent of the mammalian
cochlea, the organization and morphology of the zebrafish inner ear sensory epithelium cristae
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and maculae are highly similar to that of higher vertebrates, including human. Genetic
mechanisms governing the development and function of the zebrafish ear also appear well
conserved (Whitfield et al. 2002). Nonetheless, there are exceptions including the formation
of the otocyst by cavitation in zebrafish rather than by invagination as in chicks and mice.
Utilizing the classical forward genetic approach, many random mutations have been
generated in zebrafish through ENU mutagenesis. Mutants can be screened initially for
defects in morphology. Behavioral assays are also employed to search for mutants with
aberrant swimming patterns that are indicative of vestibular defects. Functional assays such as
generation of microphonic potentials and apical endocytosis, which is highly active in normal
hair cells, are also effective screening tools. One may also measure the startle response of
adult mutants to an auditory stimulus. This is a high throughput and automated screening that
can elicit a rapid tail-flip from zebrafish with "normal" hearing in response to a tone burst. It
can detect subtle behavioral defects that might have been missed by human observation. In
situ hybridization may also be used as a high-throughput method to identify genes with
specific or restricted temporal and spatial expression patterns, which is ideal for studying
organ specific processes.
Reverse genetic approaches have also been useful in determining the importance of
individual genes or a combination of genes' involvement in development and function of the
inner ear via suppression of expression for targeted genes (morpholino knockdown),
overexpression of a targeted gene (ectopic expression), and fluorescent reporting of targeted
genes (transgenesis). At least 22 genes have been identified so far to be necessary for inner
ear development and function in zebrafish (Nicolson 2005). Mutations in these genes can
cause defects affecting many aspects of normal hair cell specification, survival and function,
15
development of otic induction and formation of the otic vesicle. At least five forms of
syndromic or nonsyndromic human hearing disorders are known to have zebrafish models
(Whitfield 2002).
In the past decade, tremendous progress has been made in auditory research. With the
sequence completion of both human and mouse genomes and the zebrafish genome over
three-fifths complete, gene discovery and functional analysis shall proceed at an ever rapid
pace facilitated by advances in new genomic and proteomics technologies. To this end, we are
ever closer to an enhanced understanding of the hearing process that will assist in better
treatment, prevention and diagnosis of this complex disease.
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ABSTRACT
We have cloned a novel human gene, designated PFET] (predominantly fetal
expressed T domain) (HUGO approved symbol KCTD12 or Cl3orf2), by subtractive
hybridization and differential screening of human fetal cochlear cDNA clones. Also, we have
identified the mouse homolog, designated Pfetl. PFETI/PJ/tl encode a single transcript of
approximately 6 kb in human, and three transcripts of approximately 4, 4.5 and 6 kb in mouse
with a 70% GC(-rich open reading frame (ORF) consisting of 978 bp in human and 984 bp in
mouse. Both genes have unusually long 3' untranslated (3' UTR) regions (4996 bp in human
PFET1, 3700 bp in mouse Pfetl) containing 12 and five putative polyadenylation consensus
sequences, respectively. Pfetin, the protein encoded by PFETJ/Pfetl, is predicted to have 325
amino acids in human and 327 amino acids in mouse and to contain a voltage-gated potassium
(K+) channel tetramerization (Tl) domain. Otherwise, to date these genes have no
significant homology to any known gene. PFET1 maps to the long arm of human
chromosome 13, in band q2l1 as shown by FISH analysis and STS mapping. Pt] maps to
mouse chromosome 14 near the markers D 14Mit8, D 1 4Mit93 and D 14Mit 145.1. The human
6 kb transcript is present in a variety of fetal organs, with highest expression levels in the
cochlea and brain and in stark contrast, is detected only at extremely low levels in adult
organs, such as brain and lung. Immunohistochemistry with a polyclonal antibody raised
against a synthetic peptide to PFETI sequence (pfetin) reveals immunostaining in a variety of
cell types in human, monkey, mouse, and guinea pig cochleas and the vestibular system,
including type I vestibular hair cells.
KEYWORDS: novel gene, intronless, GC-rich, cochlea, predominant fetal expression,
tetramerization domain, unusually long 3' UTR, hair cells
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INTRODUCTION
The prevalence of severe to profound bilateral congenital hearing loss is estimated at 1
in 1000 births (Gorlin et al. 1995). About 50% of congenital deafness is thought to be due to
environmental factors, such as acoustic trauma, ototoxicity (e.g., aminoglycoside antibiotics),
and viral or bacterial infections (e.g., rubella, bacterial meningitis). The remaining 50% are
attributed to genetic causes and are categorized as syndromic or nonsyndromic hearing loss.
Approximately 77% of hereditary deafness is estimated to show autosomal recessive
inheritance, 22%/o is autosomal dominant, 1% is X-linked, and less than 1% segregates through
the maternal lineage via mitochondria mutations (Morton 1991). Hundreds of syndromes are
recognized in which hearing loss is among the clinical findings (Gorlin et al. 1995); over 90
loci have been mapped for nonsyndromic hearing loss (51 autosomal dominant, 39 autosomal
recessive, 1 modifier, and 6 X-linked), and to date (Van Camp and Smith, 2003) mutations in
at least 53 genes that cause deafness have been identified (Resendes et al. 2001).
We undertook an organ-specific cDNA library approach to identify genes important
for hearing, a method that has been used successfully to identify various genes including
auditory genes (Hedrick et al. 1984; Jones and Reed 1989; Gurish et al. 1992; Cohen-Salmon
et al. 1997; Soto-Prior et al. 1997; Heller et al. 1998; Jacob et al. 1998; Robertson et al. 1998).
To this end, we made a human fetal cochlear cDNA library (Robertson et al. 1994) and have
used two complementary methods to identify genes within the cochlear library. The first
strategy, sequencing of the cDNA library, resulted in over 14,000 ESTs, revealed the presence
of over greater than 1,200 known genes, over 2,200 EST clusters also expressed in other
libraries, and 700 EST clusters unique to the cochlear library (Skvorak et al. 1999; Resendes
et al. 2002). Analysis of the cochlear ESTs revealed 788 genetic loci some of which fall
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within intervals of mapped deafness loci and represent positional candidates for deafness
disorders (http://hearing.bwh.harvard.edu). This comparative sequence analysis led to the
identification of the novel gene OTOR (Robertson et al, 2000). The alternative strategy
combined the approaches of subtractive hybridization and differential screening of the
cochlear library and led to identification of genes preferentially expressed in the cochlea
(Robertson et al. 1994). As a result of the latter strategy several auditory genes, namely
ATQ1 and COCH, of which the latter is novel, have been identified from the cochlear cDNA
library (Skvorak et al. 1997; Robertson et al. 2000). COCH was further shown to be
responsible for a sensorineural deafness and vestibular disorder, DFNA9 (Robertson et al.
1998).
Herein we present characterization of a novel human gene, PFET1, identified from the
human fetal cochlear cDNA library by subtractive hybridization and differential screening,
and the characterization of its mouse homolog, Pfetl. We describe expression analyses,
chromosomal mapping and immunohistochemical analyses of the human and mouse genes.
MATERIALS AND METHODS
Differential screening of a subtracted cochlear cDNA library
Human PFET] was initially identified from a human fetal cochlear cDNA library by
subtractive hybridization and differential screening techniques utilized to identify genes
important for hearing (Robertson et al. 1994). The original partial cochlear cDNA was
designated 2E9. Briefly, a human fetal cochlear cDNA library was subtracted with human
fetal brain mRNAs by an avidin-biotin based procedure to enrich for cochlear-expressed
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transcripts. Poly (A)+ RNAs from second trimester cochlea and brain cortex were isolated
and reverse transcribed to generate 32 P-labeled cDNA probes used for differential screening of
the subtracted clones to identify those clones expressed at higher levels in the cochlea.
Isolation of cDNA clones
The human PFET1 partial cDNA, which represents the 3'-most 848 bp of the full-
length cDNA, was identified initially from the human fetal cochlear cDNA library. The full-
length human PFET1 cDNA was obtained in two phases. During the first phase, 4.4 kb of the
cDNA was obtained by using the insert from the original cochlear cDNA clone as a probe to
screen 106 recombinant phage from a human fetal brain cDNA library cloned into Lambda
ZAP II (Stratagene, La Jolla, CA). Filters were prehybridized and then hybridized at 42°C
with a 32P-labeled random-primed (Feinberg and Vogelstein 1984) probe in 10% dextran
sulfate, 4X SSC, 7 mM Tris-HCl (pH 7.6), 0.8X Denhardt's solution, and 20 ug/ml sonicated
and denatured herring sperm DNA in 40% formamide and 0.5% SDS. Filters were washed in
0.1 X SSC in 0.10) SDS at 50°C prior to autoradiography using XAR-5 film (Eastman Kodak
Co., Rochester NY) and intensifying screens at -80°C. During the second phase, the
remaining 1.7 kb of the 5' end was cloned through a computer search of the accumulated
terminal sequence data of human long cDNA libraries of the Kazusa DNA Research Institute
(http://www.kazusa.or.jp/huge) (Ohara et al. 1997). The longest clone, which was 6.2 kb in
size, was isolated from an adult hippocampus library and is denoted as pg00707.
The mouse Pfetl sequence was isolated by using the open reading frame from the
human PFET1 to search the GenBank EST database (http://www.ncbi.nlm.nih.gov/BLAST/,
EST database). One EST (GenBank accession number AW230625) was identified with 95%
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identity at the nucleotide level and contained 160 bp of the 3' end of the open reading frame
and 300 bp of the beginning of the 3' UTR. The AW230625 EST was derived from the 5'
end of a mouse IMAGE clone (accession number IMAGE: 2647463) that was obtained from
Research Genetics (now Invitrogen Life Technologies, Carlsbad, CA). Together with an
overlapping mouse clone (accession number IMAGE: 5012249), the complete sequence of 3'
UTR of mouse Pftl was determined. The remainder of the 70% GC-rich open reading frame
was cloned from total adult mouse brain RNA using 5' rapid amplification of cDNA ends
(RACE; Invitrogen Life Technologies, Carlsbad, CA). Because the ORF is 70% GC-rich,
reverse transcription was performed at 50°C in the presence of PCRX Enhancer Solution
(Invitrogen Life Technologies). For amplification of cDNA, the following PCR protocol was
performed in the presence of PCRX Enhancer Solution: initial denaturation at 97°C for 3
minutes; 35 cycles of 96°C for 30 seconds, 62°C for 30 seconds, and 72°C for 2 minutes; and
final extension at 72°C for 7 minutes. PCR fragments were TA-cloned (Invitrogen Life
Technologies) and sequenced.
Genomic clone
BLAST analysis of the PFET1 nucleotide sequence identified a 109 kb genomic clone
(GenBank accession no. AC000403) corresponding to RPCI-1 PAC clone 264J2, and this
PAC was obtained from Research Genetics. PAC 264J2 contains the entire PFET gene.
Sequence analysis
Nucleotide sequence of partial cDNA clones was determined using an ABI PRISM
dye-terminator cycle-sequencing system (PE Applied Biosystems, Foster City, CA).
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Sequence analysis was performed using the University of Wisconsin Genetics Computer
Group software (Devereux et al. 1984) and the Open Reading Frame (ORF) Finder program at
the National Center for Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.gov/).
The cDNA insert of pg00707 was sequenced using the shotgun strategy according to
procedures previously described (Ohara et al. 1997). For DNA sequencing, dye-primer or
dye-terminator cycle sequencing reactions were performed using ABI PRISM cycle
sequencing kits (PE Applied Biosystems) and the products were analyzed with ABI 373 or
377 DNA sequencers.
Northern blot analysis
Total cellular RNAs were extracted (Chirgwin et al. 1979) from second trimester
human fetal organs, adult surgical specimens, and adult mouse tissues. All human organs and
specimens were obtained in accordance with guidelines established by the Human Research
Committee at Brigham and Women's Hospital. Ten g of each sample of RNA were
electrophoresed in denaturing 1% agarose-formaldehyde gels and capillary-transferred
overnight in O10X SSC to GeneScreen Plus membranes (NEN Life Science Products, Inc.,
Boston, MA; Thomas 1980). Mouse aging brain and mouse embryonic Northern panels were
obtained from Seegene, Inc. (Seoul, Korea); each lane contains 20 ug of total RNA isolated
from either ICR strain whole mouse embryos at different stages or whole brain at different
ages.
Filters were prehybridized for 2 hours and hybridized overnight at 42°C as described
above with either 32 P-labeled random-primed probe or PCR-generated 32 P-labeled probe.
Filters were washed in 0.1 X SSC in 0.1% SDS at 42-55°C prior to autoradiography using
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XAR-5 film with intensifying screens at -80°C. A human 3' UTR probe was prepared via
random labeling from the original 2E9 cochlear clone; a human 3' UTR internal region probe
was amplified using the following primers and conditions: upper (5'
TGCAAACATGCCAAGTATTTT 3') and lower (5' AGGCAACCAGGTCTCCTTCT 3');
initial denaturation at 97°C for 3 minutes; 35 cycles of 96°C for 30 seconds, 60°C for 30
seconds, and 72°C for 30 seconds; and final extension at 72°C for 7 minutes. To generate
radiolabeled PCR fragments representing the beginning (507 bp) and end (462 bp) of the
human ORF, the following primers and the same conditions as above were used: upper (5'
CCTCTCTGTCATGGCTCTGG 3') and lower (5'TGTTCGGGCTCCGAGTAG 3'), and
upper (5' TCCTCTTCCGCTACATCCTG 3') and lower (5'
TTGAGGTAATAGCGCGAGGT 3'), respectively.
For generation of a mouse Pf/tl ORF 460 bp probe (contains 160 bp of the 3' region
of the Pf/tl ORF and 300 bp of the beginning of the 3' UTR) from mouse clone AW230625,
the following primers and PCR conditions were used: upper (5'
CAGGCCTTCG(ATAAGCTGTC 3') and lower (5' CGACATCCTGACTCTTGCAT 3');
initial denaturation at 97°C for 3 minutes, 35 cycles of 96°C for 30 seconds, 58°C for 30
seconds, and 72°C for 30 seconds; and final extension at 72°C for 7 minutes. For generation
of the mouse Pf'etl 3' UTR probe 1 (400 bp), the following primers and PCR conditions were
used: upper (5' GGCTCATAGGACAGCACCTC 3') and lower (5'
GCATGGCTGCACATCAGATA 3'); initial denaturation at 97°C for 3 minutes, 35 cycles of
96°C for 30 seconds, 60°C for 30 seconds, and 72°C for 30 seconds; and final extension at
72°C for 7 minutes. For generation of the mouse Pfetl 3' UTR probe 2 (394 bp), the
following primers and PCR conditions were used: upper (5'
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GAGGGAATCGTTTTGATGTGA 3') and lower (5' CCCAGCAATTTATGGAGTTGA 3');
initial denaturation at 97°C for 2 minutes, 35 cycles of 96°C for 30 seconds, 60°C for 30
seconds, and 72°C for 30 seconds; and final extension at 72°C for 7 minutes.
Gene mapping
A human PAC (246J2, GenBank accession number AC000403) containing the entire
PFETI gene was obtained from Research Genetics and used to generate a biotin-labeled
probe for fluorescence in situ hybridization (FISH). About 3 pg of PAC DNA were labeled
with dNTPs conjugated with biotin (Boehringer Mannheim, Indianapolis, IN) according to the
manufacturer's protocol, precipitated with 6 ~tg of Cot-1 DNA (Gibco-BRL, Rockville, MD)
and resuspended in 30 tl hybridization buffer (50% formamide, 2X SSC). Hybridization of
metaphase chromosomes from peripheral blood lymphocytes obtained from a normal male
was performed using 0.5 - 1 pg of labeled probe. The biotin-labeled probe was detected using
Cy3 avidin (Amersham, Little Chalfont, Buckinghamshire, UK) and chromosomes were
counterstained with 4,6-diamidino-2-phenylindole dihydrochloride (DAPI) (Vysis, Downers
Grove, IL). The map position of the PFET1 gene was determined by visual inspection of the
signal on the DAPI counterstained metaphase chromosomes. Chromosomes and signals were
observed with an Olympus AX70 photomicroscope and photographs were captured using a
Photonics CCD camera and Genus software (Applied Imaging, Santa Clara, CA). Mapping of
the mouse Pfetl gene was performed by using the 3 kb mouse sequence to search for identical
sequences in the Celera mouse genome database (Celera, Rockville, MD).
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Tissue preparation for immunohistochemistry
Three mice (6-8 weeks), two guinea pigs (less than 3 months), one monkey (unknown
age), one adult human (68 years) and one fetal human (20 weeks) cochleas were used in this
study. Human fetal tissues were fixed in 4% paraformaldehyde in PBS at 4°C for 2-3 weeks
and then decalcified in 0.1 M EDTA in PBS at 4°C for approximately 2 weeks. The human
adult temporal bone was retrieved during autopsy; postmortem time is unknown. All tissues
were prepared for paraffin sections in the following manner. Animals were anesthetized via
intraperitoneal injection of urethane (1.5 g/kg), and exsanguinated through transcardial
perfusion of saline with 0.01% sodium nitrite, followed by fixative. Fixatives used were
formalin acetic (FA: 10% formalin and 1% acetic acid in PBS) and formalin glutaraldehyde
(FG: 10% formnalin and 0.1% glutaraldehyde in PBS). The bulla cavity of each animal was
quickly exposed and 0.2-0.5 ml of fixative was injected slowly into the scala tympani through
the perforated round window. Specimens were kept overnight at 4C in their respective
fixative followed by one week in 120 mM EDTA pH 7 for decalcification. For human
specimens, decalcification was performed up to a month. The decalcified specimens were
dehydrated in a series of ethanol solutions and xylene baths before embedding in paraffin
(Imamura and Adams 1996). Serial 8 ptm sections were cut and mounted on glass slides.
Human fetal tissues were obtained following guidelines established by the Human
Research Committees at Brigham and Women's Hospital and the Massachusetts Eye and Ear
Infirmary. The care and use of animals were in accordance with NIH's "Principles of
Laboratory Animal Care" and was approved by the institutional committee on animal care at
both institutions.
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Immunohistochemical staining
Polyclonal antibody was raised in rabbits against a synthetic peptide corresponding to
amino acid residues 256-280 of PFET1 human sequence, coupled to KLH (keyhole limpet
hemocyanin) (Research Genetics). This region of PFET1 is highly conserved in mouse.
Antisera were affinity purified using the pfetin peptide. In order to obtain pfetin as a positive
control for Western analysis, the open reading frame of PFET1 was cloned into vector
pET28a to express the protein (Novagen, Madison, WI). Pfetin was also extracted from
various adult mouse organ tissues that were shown to contain PFET1 mRNA through
Northern analysis. For a negative control, the pET28a vector only and the pET28a vector with
another unrelated ORF were used. All protein was expressed in bacterial cell line BL21 (DES)
(Stratagene, La Jolla, CA). Immunostaining of paraffin sections was performed with the
biotinylated tyramine (BT) enhancement method (Adams 1992). Paraffin sections containing
the cochlear regions were deparaffinzed, hydrated, and rinsed in deionized water and PBS.
Sections were blocked with 5% normal horse serum (NHS) in PBS for 30 minutes and then
incubated overnight with primary anti-PFET 1 antibody diluted between 1:1000 and 1:4000 in
1% NHS-PBS at room temperature in a humid chamber. Sections were rinsed with PBS and
incubated for an hour in a 1:1000 dilution of biotinylated goat anti-rabbit IgG (Vector
Laboratories, Inc., Burlingame, CA) in 1% NHS-PBS. Sections were rinsed in PBS and
incubated with Vectastain ABC reagent (Vector Laboratories). After an hour, sections were
rinsed in PBS and incubated with BT diluted 1:100 in 0.01% H20 2 for 10 minutes, rinsed in
PBS, and incubated with ABC reagent for another 30 minutes. The primary antibody was
visualized using 0.05% DAB (3,3' diaminobenzidine) in 0.01% H20 2 and 0.1 M phosphate
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buffer. Controls for the immunostaining procedures were done with serial dilution of the
affinity-purified primary antibody and with 1% NHS-PBS containing no primary antibody.
RESULTS
Identification of human PFET1 by subtractive hybridization and differential screening
To identify genes preferentially expressed in the cochlea, subtractive hybridization and
differential screening techniques were performed using a human fetal cochlear cDNA library.
Subtracted cochlear clones were differentially screened with 32 P-labeled total fetal cochlear
and total fetal brain cDNA probes identifying those clones that were highly or preferentially
expressed in the cochlea (Robertson et al. 1994). Slot blot analysis revealed that PFET1 had
an increased level of expression in cochlea as compared to brain (data not shown), and led to
its selection for further analysis.
Nucleotide and amino acid sequence analysis
To identify the full-length sequence of PFET1, human fetal brain and adult
hippocampus libraries were screened and yielded several overlapping cDNA clones. The
longest clone (6.2 kb) was isolated from the adult hippocampus library and represented the
full-length sequence of PFET1, containing a predicted full-length open reading frame (ORF)
of 325 amino acids encoded by one exon and a 3' UTR of 4996 bases containing twelve
polyadenylation consensus sequences (Figs. 1 and 2). The detailed information of the isolated
clone is available on a Gene/Protein characteristic table for KIAA1778 of the HUGE database
(URL, http://www.kazusa.or.jp/huge). Analysis of the upstream sequence revealed a Kozak
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sequence (GCCCGGCCACCN 8ATGG) (Fig. 1). The 240 bases 5' to the ORF and the entire
ORF are very GC-rich (78% and 70%, respectively) (Figs. 1 and 2). BLAST analysis (dbNR)
revealed homology to no known genes in GenBank, identified one partial human fetal brain
mRNA clone designated 24475 (GenBank accession number AF052169), and one
chromosome 13 PAC clone designated 246J2 (GenBank accession number AC000403).
BLAST analysis (dbEST) revealed homology to 279 ESTs from various human libraries,
including fetal cochlea (n=31), adult and fetal brain (n=29), adult heart (n=14), adult kidney
(n=16), adult lung (n=17), adult ovary (n=17) and adult muscle (n=5). The findings of a
consensus Kozak sequence, and that longer transcripts containing additional 5' sequence were
not revealed by RT-PCR (data not shown), library screening or computer searching of public
databases, suggest that the 6.2 kb clone contains the entire gene.
One mouse EST (AW230625) with 95% identity at the nucleotide level and containing
part of the ORF (170 nucleotides of the 3' end of the ORF) was identified from GenBank
(mouse dbEST). The remainder of the mouse Pfrtl ORF was cloned from mouse brain total
RNA by performing 5' RACE. The remaining 3.4 kb of the mouse Pfttl 3' UTR was
obtained by sequencing IMAGE clone 5012249 that overlapped with mouse AW230625 EST
(see Materials and Methods). Like its human homolog, the mouse Pfetl gene has an
unusually long 3' UTR (3700 bp) and contains five putative polyadenylation consensus
sequences (Fig. 4).
The protein domain database, Pfam (Bateman et al. 2000), was used to identify protein
motifs or domains in the predicted amino acid sequence. A voltage-gated potassium channel
tetramerization (T1) domain of 95 amino acids, spanning amino acids 34-129, was identified
(E = 7.3e-17) in the amino terminal region (Figs. and 3). No other complete domains were
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predicted. A hydropathic profile utilizing the Kyte-Doolittle method revealed four weakly
hydrophobic regions of at least 10-15 amino acids (data not shown). The deduced amino acid
sequence does not appear to contain any transmembrane spanning domains, as determined by
the transmembrane prediction programs TMpred (Hofmann and Stoffel 1993), TMHMM
(Sonnhammer et al. 1998), and HMMTOP (Tusnady and Simon 1998).
The human PFET1 and mouse Pftlgenes are 91% identical at the nucleotide level
within the ORF and share little sequence similarity outside of the ORF (Fig. 2). The mouse
ORF is longer by two amino acids (insertion of proline and histidine at positions 142 and 143,
respectively) and the predicted protein differs by eight amino acids (Fig. 2). The human and
mouse pfetin are predicted to have 325 amino acids in human and 327 amino acids in mouse
and to contain a voltage-gated potassium channel tetramerization domain. The entire human
and mouse ORFs are very GC-rich (70%). The tetramerization domain in the mouse PJtl is
identical to that of the human PFET1 except for a phenylalanine to leucine change at position
88 (Fig. 2).
Northern blot analysis
To determine the relative level of expression of human PFETi mRNA in various
tissues, Northern blot analysis was performed using the original 3' cochlear cDNA clone (0.9
kb of 3' UTR) to probe a panel of human fetal RNA samples (Fig. 5). One transcript (-6 kb)
was revealed at high levels in human fetal cochlea and brain, at moderate levels in skeletal
muscle, lung, ovary and eye, and at lower levels in thymus, tongue, heart and adrenal gland
(Fig. 5A). A Northern blot panel of adult and fetal human organs was hybridized with
different PFETI probes (Fig. 5 B and D). In contrast to the abundant fetal expression pattern,
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the -6 kb PFET1 transcript was present at barely detectable levels in adult tissues studied,
such as spinal cord, cerebrum, cerebellum, skeletal muscle, lung and lymph node (Fig. 5B).
Low expression levels of the PFETI transcript were also detected in adult liver, heart and
kidney (data not shown). The transcript was also detected in various regions of the fetal brain
(Fig. 5C). Other smaller-sized bands, in particular a -4.7 kb band, were identified by probes
made from the PFET ORF (Fig. SB, ORF probe) and are thought to be due to nonspecific
binding since the ORF region is 70% GC-rich and because the 3' internal UTR probe, which
would be expected to be present in a transcript of this length, does not identify these bands
(see Fig. 5B, 3' UTR internal).
For Northern blot analysis of total RNA from adult mouse tissues, we initially used
the "ORF probe" containing part of the 3' ORF region and part of the 3' UTR. A single -6 kb
transcript was revealed at low levels in most adult mouse tissues tested (Fig. 6 A and D).
Then, using a probe to a downstream 3' UTR region ("3' UTR probe ," which overlaps with
the "ORF probe"), three transcripts (approximately 4, 4.5 and 6 kb) were identified in samples
containing aging mouse brain and whole mouse embryos at different embryonic stages (Figs.
6 B, C and D). The intensity level of the largest Pfetl mouse transcript identified during
embryogenesis appears to increase between days 11.5 and 15.5, while the intensity level of
the smaller mouse transcripts seems to peak earlier, from days 6 to 15.5 (Fig. 6C). In addition,
there appears to be a noticeable decrease in expression level of the largest mouse transcript
between weeks 2 and 4 of development in mouse brain (Fig. 6B). The smaller transcripts are
not as apparent in the adult tissue panel, and most likely reflect the lower concentration of
RNA used to prepare that Northern blot. Interestingly, the smallest mouse transcript (- 4 kb)
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was not identified by a probe derived from the 3'-most mouse region (3' UTR probe 2) (data
not shown) suggesting the use of an internal polyadenylation sequence.
Northern blot analysis utilizing probes derived from different regions of the human
gene gave the same results as obtained with a 3'-most probe, and revealed the presence of no
additional transcripts for both the human and mouse genes (data not shown).
Chromosomal mapping in human
Physical mapping of PFET1 was done to determine its chromosomal position and to
access whether it is located within a region of any known deafness loci, making it a positional
candidate gene for that deafness disorder. Initially PFETI was localized to chromosome 13
by virtue of its sequence homology to a genomic chromosome 13 PAC (GenBank accession
no. AC000403. PAC 246J2) and to several chromosome 13 STSs (SHGC-15652, WI-17550
and TIGR-A002N08). PAC 246J2, which contains the entire PFETI gene, was FISH-mapped
and localized to band q21 on chromosome 13 (Fig. 7). Currently, PFETI is not a candidate
gene for any known deafness disorder as none have yet been mapped within this
chromosomal band (Van Camp and Smith 2003). The mouse Pfetl gene was mapped to
chromosome 14 near the markers D14Mit8, D14Mit93 and D14Mitl45.1 as determined by
sequence identity with the Celera sequence GA_xSJ8B7W5YOC. Human 13q21 is contained
within a region of homologus synteny in mouse chromosome 14 and thus far, no mouse
deafness mutant has been identified near Pfetl gene region
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Immunohistochemical analysis
Before immunostaining was attempted, the antibody was tested for purity and
specificity using Western blot analyses. The analyses of purified pfetin antibody on both
bacterially-expressed proteins and tissues extracted from various mouse organs (6 months old
brain, heart and skeletal muscle) showed one distinct band between 35 kDa and 47 kDa, the
expected size of pfetin, for the positive control but not for either of the negative controls (data
not shown).
The mammalian cochlear and vestibular systems consist of various cell types. In the
cochlea, the greatest number of immunostained cells were type I fibrocytes in the spiral
ligament (Fig. 9). This finding was observed in all species, including human, monkey, mouse,
and guinea pig (Fig. 9 and lOB). Immunostaining was also localized in the following cochlear
cell classes: types IV and V fibrocytes, Deiters cells, inner and outer pillar cells, inner sulcus
cells, interdental cells, supralimbal and limbal fibrocytes (Figs. 9 and 10). Type V fibrocytes,
also called suprastrial cells, were positive for immunostaining near the Reissner's membrane
in human (Fig. lOD), monkey (Fig. 9C), guinea pig (Fig. 1I C) and most of the mouse
cochlear sections (Fig. 9B). While immunostaining of limbal fibrocytes and supralimbal cells
was observed in mouse, guinea pig, monkey and human cochleas (Fig. 9 and 10),
immunostaining in Deiters cells, inner and outer pillar cells and interdental cells was observed
only in mouse and guinea pig (Fig. 1 A-C). Immunostained neurons included spiral ganglion
cells (Fig. 9B), Scarpa's ganglion cells and Purkinje cells in mouse sections containing brain
tissues (not shown).
In the vestibular system there was apical immuno-staining of the type I hair cells at the
cuticular plate and in the hair cell cytoplasm (Fig. 12G and H). Beneath the sensory
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epithelium, connective tissue cells were also immunostained in formalin plus glutaraldehyde-
fixed mouse (Fig. 12H) and guinea pig ampulla (Fig. 12 E, F and H). Positively stained
fibrocytes extended from beneath the sensory epithelium to the area beneath the vestibular
dark cells. Adjacent to the sensory epithelium, transitional cells and cells beneath the
vestibular dark cells in human fetal and guinea pig (Figs. 12A, B, E, and F) were positive. In
addition, positive cells were present facing the lumen of the semicircular canals in human
fetal tissue (Figs. 12C and D) and along with the lumenal and ablumenal surface of formalin
plus glutaraldehyde-fixed mouse and guinea pig semicircular canal (Fig. 12E, F and H).
These immunohistochemcial analyses were performed mostly on adult tissues, since fetal
tissues were not available at the time of this study. Although Pfetin has a low expression in
adult tissues, nonetheless it is expressed in a variety of adult organs and therefore the
immunohistochemical analyses on adult organs remains a reasonable initial study to carry out.
Immunohistochemical analyses on fetal organs are pertinent and such future analyses will be
performed.
DISCUSSION
We have cloned and characterized a novel intronless human gene designated PFET1
and its mouse homolog, Pfrtl. The open reading frames of PFETI and Pftl are unusually
GC-rich (70%); the potential significance of this is not known. The encoded proteins of both
genes contain a tetramerization domain characteristic of voltage-gated potassium channel
subunits. The 3' untranslated region from the human gene is long (4996 bp) as the average 3'
UTR length for human mRNAs deposited in public databases is between 740-755 base pairs
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(Pesole et al. 1997; Pesole et al. 2000). The role of the unusually long 3' UTR in this gene is
presently unknown. Although 12 putative polyadenylation consensus sequences are predicted
in the human sequence, the finding that 5' and 3' probes identified only the largest transcript
suggests that the other 11 putative polyadenylation consensus sequences may not be utilized
to produce alternatively-sized transcripts. It remains possible that other PFET1 transcripts of
different sizes exist and are at levels below the limits detectable by Northern blot analysis or
are expressed in a different temporal or spatial fashion not tested.
PFET1 encodes a single 6 kb transcript and its mouse homolog encodes three
transcripts (4, 4.5 and 6 kb). In humans, a 6 kb PFETI transcript is expressed abundantly in
a variety of tissues in the fetus and at strikingly lower levels in the adult. The observation that
PFT1 is expressed at much higher levels in fetal organs than in adult organs is intriguing.
This expression difference in adult and fetal tissue samples appears also to occur with the
mouse Pfrtl transcripts in brain (compare Fig. 6A, 6B). The disparate expression levels of
the PFET1 6 kb transcript cannot be explained by the expression of tissue-specific or age-
specific alternative transcripts as both 5' (containing part of the ORF) and 3' UTR probes
identified only a single transcript, the -6 kb transcript, in all fetal and adult human tissues
tested (see Fig. 5D for position of probes). PFET1 is the first example to our knowledge of a
human cochlear gene with such disparate expression patterns in adult and fetal human organs
as late as second trimester developmental age in humans. Similar type of expression has been
seem before in other species like mouse, zebrafish, xenopus and chick with genes like
GATA3, Pax2, Bmp4, and Bmp7 etc. This type of expression pattern suggests that PFET1
has a developmental role and thus is required at high levels during embryogenesis and at
much lower levels in adulthood. Of note, the human fetal cochlear library from which PFET1
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was identified represents largely developmental ages of 16-22 weeks, consistent with cochlea
that are morphologically adult-like in structure. There is also evidence that the human fetus
responds to sound at about this age. In light of these observations, it is interesting that there is
a marked difference in expression levels of PFETI in the fetus versus the adult, suggesting a
potential important role of PFET1 in further development of the cochlea during later stages of
fetal life.
Tetramerization domain
Voltage-gated potassium channels, of which there are multiple families, each
consisting of numerous members, are assembled as homomeric and heteromeric tetramers
from membrane-integrated c subunits; the Shaker-related potassium channel also
coassembles with cytosolic f3 subunits (Jan and Jan 1997; Pongs et al. 1999). The assembly
of different subunits to form functional heteromeric tetramers is thought to be determined by
the amino acid composition of the tetramerization (T1) domain, and thus contributes to the
diversity of electrical responses that a cell can generate in response to changes in membrane
potential (Bixby et al. 1999). Therefore, it is not surprising to observe some sequence
variations in the conserved regions within K+ channel tetramerization domains amongst
family members given the existence of a K+ channel tetramerization domain consensus
sequence (Fig. 3). The exact role of the T1 domain remains controversial. Previously, it was
shown that the T domain is not necessary for K+ channel assembly or function (Kobertz and
Miller 1999). Rather, the T1 domain of voltage-gated potassium channel subunits may act
more as a segregation domain in that it ensures that tetramerization occurs only among
subunits belonging to the same family and that cross-family subunit assembly does not occur
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(Li et al. 1992; Shen and Pfaffinger 1995). The T1 domain may also function as a docking
station for the subunit of voltage activated potassium (Kv) channels such that the removal of
the T1 domain (lisrupts 3 subunit association (Sewing et al. 1996; Gulbis et al. 2000).
Because the predicted ORF of PFET1 contains a tetramerization domain, it is tempting
to speculate that pfetin may be a novel voltage-gated K+ channel subunit that could contribute
to tetramer diversity and thus could participate in a variety of electrical responses of the cell.
Furthermore, the deduced amino acid sequence of pfetin is predicted to contain four
hydrophobic regions of at least 10-15 amino acids in length. However, since PFET is
predicted to contain no transmembrane domains, and six are characteristic of voltage-gated
potassium channel subunits, it is unlikely that PFETJ encodes another member of the voltage-
gated potassium channel subunits.
Relationship between TI and POZ domains
The voltage-gated potassium channel tetramerization domain is thought to have a
structural and evolutionary relationship to the BTB/POZ (for bric-a-brac, tramtrack, broad
complex pxvirus and zinc finger) domain, which is found in a variety of proteins involved in
transcriptional regulation, cytoskeletal organization, and development (Aravind and Koonin
1999). The POZ domains of the mammalian transcriptional repressor proteins BCL6 and
PLZF (promyelocytic leukemia zinc finger) interact with the transcriptional corepressor
proteins mSIN3A and SMRT (silencing mediator of retinoid and thyroid hormone receptor),
via a paired amphipathic helix 1 (PAH1) domain (David et al. 1998), and multiple SMRT
contacts (Hong et al. 1997), respectively. Chromosomal translocations involved in human
leukemias generate fusion proteins, such as RARA-PLZF, containing POZ domains that play
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an important role in the pathology of the disease (Hong et al. 1997; Grignani et al. 1998; Lin
et al. 1998). The BTB/POZ domain, like the voltage-gated potassium channel T1 domain, is
important for protein-protein interactions and allows for dimerization of BTB/POZ domain-
containing proteins. However, unlike the voltage-gated potassium channel TI1 domain, POZ
domains mediate interaction between proteins containing other domains as well. Future
studies are necessary to determine if the T1 domain present in PFET1/Pfetl is functional and
possibly acts like a BTB/POZ domain, allowing for the interaction of PFET1/Pfetl with
proteins containing various types of domains.
Immunohistochemistry of pfetin antibody
Perhaps the most numerous cochlear cells that were positive for pfetin were type I
fibrocytes of the spiral ligament in the cochlea. Fibrocytes of the ligament are thought to be
part of the connective tissue cell gap junction system (Kikuchi et al. 2000) and may play a
role in K+ recycling by transporting K+ to the stria vascularis (Spicer and Schulte 1997). The
loss of type I fibrocytes of the spiral ligament is the predominant histopathology of DFNA9
(Merchant et al. 2000), a known autosomal dominant, nonsyndromic, progressive
sensorineural hearing loss (Robertson et al. 1998) . These are also the cells that are most
severely disrupted in the hydropic guinea pig (Ichimiya et al. 1994). The type I fibrocytes,
containing enzymes such as intracellular Ca++-ATPase, carbonic anhydrase, aldehyde
dehydrogenase and calcium-binding proteins, are thought to be involved in the regulation of
cochlear fluid and ion balance (Ichimiya et al. 1994; Spicer et al. 1997). Although the exact
function of type I fibrocytes in cochlea has not been clearly defined, it is quite obvious that
their loss in DFNA9 show that they play an essential role in normal auditory functions.
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Besides type I fibrocytes, pfetin antibody also stains type IV and type V fibrocytes cells in the
cochlea across different species tested. Pfetin antibody immunostaining in limbal fibrocytes,
supralimbal, Deiter, interdental and pillar cells were less consistent. One possible explanation
is species-specific expression of pfetin function in the cochlea. The amount of antigen
available for pfetin antibody binding might vary somewhat as well depending on the plane of
the section giving certain cellular structure a better exposure. However, the quality of tissue
fixation might also have contributed to some of the staining variation. Initial attempts at
immunostaining formalin fixed mouse cochlea were negative. Experimentation with other
fixatives revealed consistent staining patterns with tissues fixed in formalin plus
glutaraldehyde. Although human material that was promptly fixed with formalin plus
glutaraldehyde was not available, it seems likely that the immunostaining results from the
human sections is credible because of its similarity to the patterns of immunostaining seen in
animal tissue where control of fixation was possible. It remains to be confirmed that
vestibular hair cells and fibrocytes are pfetin positive in human material.
It is striking that most of the cell classes stained by pfetin antibody in the cochlea have
been implicated in the potassium recycling pathway through putative lateral uptake by Deiters
cells, forwarding through supporting cells, outer sulcus cells and spiral ligament fibrocytes
and on to strial marginal cells. Given the cell types stained by pfetin antibody and their
associated function in the cochlea, it is possible that pfetin plays a role in ion transport or
ionic content regulation in the cochlea. This hypothesis is especially intriguing given the
presence of the T domain in pfetin, since this domain is characteristic of K+ channel
subunits.
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An exciting discovery came from the vestibular sensory epithelium where the cuticular
plate and the cytoplasm of the type I hair cells were immunostained. Although the function of
this gene product is not yet clear, loss of gene function would likely result in a vestibular
phenotype if pfetin plays a key role in hair cell function. Similar to the type I fibrocytes
stained in the cochlea, connective tissue cells in the vestibular system show pfetin
immunostaining as well. Specifically, immunostaining for pfetin in the human fetal, mouse
and some guinea pig vestibular sections reveals a positive signal in a layer of cells underlying
the transitional cells and vestibular dark cells. In mouse sections, the connective fibrocytes
underneath the vestibular sensory epithelium are prominently stained by pfetin antibody. The
functions of these cells are not known. In addition, little is known about the pfetin positive
cell layer that lines the lumen of semicircular canals. They form the barrier that faces the
endolymphatic space. It is possible that they play some role in ionic content regulation in the
vestibule. Because T1 domains are members of the POZ domain superfamily, and some
proteins containing these domains are involved in cytoskeletal organization, pfetin may also
function, by protein-protein interaction via the T1 domain, in the structural organization of the
cochlea and vestibule. Given the presence of pfetin in a variety of cell classes such as sensory
cells, nerve cells, epithelial cells and connective tissue cells in the cochlea and vestibular
system, it is likely that pfetin could have broad functional roles in inner ear and vestibular
system. Additional studies are needed to further elucidate the function of this intriguing novel
gene.
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TCATGCAGTTTGTTTGl~GTTAAGTGGAP.TCCTTTCAAl,TGACGAGCTGC
AGAG~~CTCAGCACCAAGGGCTGCCTATCTGTAGATAGCTGThAAATGGA
ATATTTTTAAATGAAGGCAAATAAGTACTTAAAAGTGAGCTGAGCIIIII
I~TGGTCCAATAATAGGTAAATGCAACAGAAACAGAAGGAGACCTGGTTG
CCTTATGCCTTTACTCTTACATGGIIIIIITTCCCPATGCATATCCTATG
TAAACCATAAGTGAAGGGAIIIIIICCTCGTCATGCTCCATGCTGTGAGG
TGTCCTTTGGATATTCTGTGATGACAGAGAAGCCTATTTTGTTTTGTTTT
CAGCATCTTTCTCTGATGTACGTTTTTAAGGATTTTGTAAGAGCTGTTTT
CAGTGTTTN~TTAGTGCTATTTTTCCTTGTTTTTN~TGAATCTCGT
ACTGTATCTTACTATGTCCATACAGATGTTACAAATCGACAGTTTTATTC
TTAGACTCATGTGATCCAAGCTGTATATACCATATATAAACATTTTACAT
GAATCATTTAGTTTTTTAATTCATTTACTAATGCTATAAAATTTCCTATA
TTACCCCAGTAATTTGCATCAGCTGGTTTATATACTAAAGCAACATGTTT
TGATGAGTTTCTTACATCCTTATCGAGGAATTGGGTTAGGAAAAAATACA
TAATTGTAN~CTGAGTTTGCTGTATTATACTTTTTTTCTTGAGTATTAG
TTGTATTACTAATCATATGTTGATTAACTGTCTACTTAAAGTCAAGGTAC
CTGTATTTTTAATCCACTAATTTTTTTTTAGTTGGGAAATAGATTTCAAG
TCTTTTATTAGACTAACATTTTTTGAGAAGTAAAATTGACTTTATATACA
AAGCCTGTAATTTTAGGCGAAATGGAAGCAGAAATCTAGGAAGTTGTGCT
TGCTTGTATGGTCTCAGACTAAGTAATGCATCAGAATTCATCTGTTTGAA
GCCTGAAATAATTTAGGACTCTGATTCACTGACCAAAAGTCAGTGTTGCA
GAGATTTCTCTACCCCGTATGGTATTTTGTTAGATTGTTCAACAGGAAGC
ACATGATTGAGhACATCTTGGGACAGACCAAAACCACTGACAGATGGCAA
GGCTCGGCGATTCTGATTTCCCTTCTCAAATCTGCTCAACTCCAAGAGTC
TTGAGAAACTGCT~.TTTTGCCTCTGTCACTCAAGTCTTACAAATGTT
ATCTTGTAAACCTTTGAGGTGAACTATTCCACTGTCTTGTACATAGGCAT
CTTATTCACTGCACCCTGTCACACCCAGCACCCCCCGCCCCGCACATTAT
TTGAAAGACTGGGAATTTAATGGTTAGGGACAGTAAATCTACTTCTTTTT
CCAGGGACGACTGTCCCCTCTAAAGTTAAAGTCAATACAAGAAAACTGTC
TATTTTTAGCCTAAAGTAhAGGCTGTGAAGAAAATTCATTTTACATTGGG
TAGACAGTAAAAAACAAGTAAAATAACTTGACATGAGCACCTTTAGATCC
CTTCCCCTCCATGGGCTTTGGGCCACAGAATGAACCTTTGAGGCCTGTAA
AGTGGATTGTAATTTCCTATAAGCTGTAATAGTGGAGGTATTGTGGGTTC
ATTTGAGTAAGCCCTCCAAAGATACCATTCk~ATAACCTGGGAGAATGTC
ATAAATTATTCAGATAATTATCACTGCATGAATCTGATTCAGAGGCATGC
ATTTACATATGTTGCCCTAATTACCATTTGATGATCATAAATACAAGTGA
ATGACATTGGACTTTTAGThACAAACTTAATTTTTAAAAAAGTGTAGACA
ATGGTGGTTAAAAAAAAAAAAAACAGGTGCCAGGTTCTGTGTGTTTGCAC
CAAGTPATTGACATGTTTTTTGTTTAATACATGTGGACCATGAACAGTAT
TCATTCTACTTTTTCA~~TGATATGCTGTAGAAAATATTCCTTGAAGATG
TGAGATTTAAAAATTTTTCCCTTTCAATGTTGTTTTAATTGTATTTCTTA
CTTGGTTTTTTTGATTGATAGCACAGTGATAAATCATAATACTAGACAAA
ATTGTCTTCTCTTTCAAACCAGAGCCATATATATGTCTGTATATATGGGA
CCTACTGCTTCTCTGAGGAAATGCATAATCTGTTAATATCAGACAAAATG
AGC~~TTGGCAGTGCTCATAATATATTCCAATTTTTATTGGAATTTTCGA
TGGAATGTTATTTCIIIIIIGCCATGTAAGGTGAAACTTTGATAACTTTT
TACTCTTCAAGTTAGGGTAAATTCTGATCCAATATTCAATTCATTTGTGT
ACTCCCACATGCAAAATGCTAAATTACAATGCAGACATTAAGAAAAAGTA
TTGACTGGAGGGGTTGAATTCCTTGAGAATTTATTTTATAGTCTAAATCA
CAAATACTTTACTCAATTTAGTTTTTAAAATAGTAAACTGAATATTTTTG
TTGTAAGCCTATCAGAGTCAATCCTTCGTTTGGAATTGTTTTCCTGTTTT
TCCTTACTATAAATCATTTAAAAACTGAATTCATTTTCTTAGATGGCATA
AGTCTGTCTCTTGAGAAATAAGTAAAATACTCCTATTTTCAGTATCTGTA
GCACCTGAAATAGGTCTTTGTATAGCCAGAAACAAGTTATGTTGAAGTTA
GCTTTTCTTTGTCAACAGTTTTGGACIlllllAATCTGAAAGTATTAACA
CTTGATTTTCTACTGGGGCCCTTCAAACTTGGTTGGAAGAAATTCAACCA
GAATATCTACATTAGAGTATAATCATGTGTGGTAGGAAGATGGACTAGTT
AATCAAGATTTGTTGTCACTTAAATTTTTTGTGATTTTTTTCCAAGCCAG
TTTTTTTAAATTCTAAATGTGTTTTGAGGTATGGGTACATTfu\TTGTAAT
GTAAACTATTATACAACTGTTTTTGCGACTTTATAGGCAGGTAAATTTTG
CTATTACTATTGAATACAAATGACAATTCATTTATGACCACTCAAACAGC
GTTAGTAACCATTTAGTGACAAAGGIlllllACATCCATCTGGATGTTAA
TTTTGAAGATGTAAATTATATGTTGTTTAAATTTTTCCAGGCATCTGAAA
ACCTTATCTGCTAGACAATGTAAGATTCACACAGAGTTATCTGGGATTCT
GATTTTTTAAATAGTACATATCllllllccATTTTCTCTAAATGTAAGAA
GAGCAGAAAAAATCTTATAAGATTATCAGATTTTTCTAATGACACAGAAA
TGTAAGAAAAAAATCCCTTTATATTG~~AGATGCAGTCAAAGTCTTT
TCAGACATGCCCAAACTTTGAGAATTCCTTCAACCATCTAATGCTATAAA
GATTTTTGTTCTTCCTGTTCACAACCAGTTGTATAACAGAAATACTAGCT
ACTGTTTTCCTTCCTGTGTGTGAAGTAATGAATCATTGATTATGTGACTT-GTTATGTATTC CACTAAAG CATTCACTCCTTT
Figure 1. Nucleotide sequence of human PFETl cDNA and its deduced amino acid
sequence. Nucleotide numbcrs arc shown on the left and amino acid sequence
numbers are shown in parentheses on the right. The Kozak consensus sequence is
outlined in red. The tetramerization domain is underlined. An asterisk deIlotes the
stop codoIl. Putative polyadenylation consensus sequences are shaded. The boxed
sequence represents the original clone obtained from the cochlear eDNA library.
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GCTCCCCAGACCCCCTCGCCACTCCAGCGCCCAGTCCTTCTCCTGCCCGA
GAGATGATTACAGAGCCTCTTGTCCCACCTTTGTCCCCTGGCTGCTGCCC
TCCCATTCTCCCCCTCCAGTAGTAGCTGGGTGAGACCTGTCCGCCCACCT
TCCCTCCACTACAGAACCTGCAGCCGCAAATCCTCTGGGCTGCTTCGTCT
TCTTTGGACCTCCTGAACCGAGAGAnCCCAGAGGAnCCCCCACCCCACCC
CCACCTACCACTCCATGCTTTCTCTACTCCCTGCCTCAAACCACCCCTCC
CCCAGATGGTACTTCAGTTTGGATCTATTGGGGGAGTGTGGCCACAGACC
GGGGGATGATTGAATTGTTCAG~~CCTGATTGGACCGTGTCCAATGTGCG
GAAGATTTCCTTGAAATCTTCTCAAGCTCTTATGACTCACTGGGGGTTTA
AGAGATCAGGATTGGTTCCACTGTCTGGGGTTAGTGTTTTACAAGGTCAT
TACACAGTCTTTTTGACCTCTTTTGAAGGTAGAGTTTTAGAAGGCTGGAT
GGAAGATTCTGAGCCTGGAATTAGGACCCCATGGAGGCAGTTCAGTAACT
AAACTIIIIIIGTTTTGAAAAGTTACACGTAAAGTAGAAGAATCTAGTGC
GTGGGACAGTAAAGGATCCTTTCTCGTACAGIlllllAGGTCTCAGCCTG
TAGCTTAAACTTATAGAAAGTGATCCGCCTGCCTGCAGAGGCGCCCTTTT
CAGCTGCTGCTCGCCAGAAGCCCTTGATTCCACTGGTTGACATGGCAGCA
GTTACTGGCAAGAGGGAGAAAGGACGCTGCCGCCTAAGAGTGCAAGGCTG
CTCAGGTCTCCAAGCGCCGTAGGAGGTCACCTGGCAGTGACTGTAGGGAG
CTGGGTCATAGTGCACGTCGTGGGTATTAGGAAAGCCTGTATTCTTTCAA
TGAATGTCAGTAGGACCTTCCTTTAGCTGTAAGACTTGGTGGGCGGGGTG
GGGTGGGGAGGGAGGAAAGGGTAGGAAGGGTGGGAAGGGAGAAGCAGACA
TAGTCATTTATGATTTGAAAGTTGGAAGTTTGTACCATCTGTTTGAGTAT
ATGCACATTTAAAAAATATCATATAGTAAATGCAAACATGCChAGTATTT
TATAAAGATTAATAACAGACCTACTCTTACCTGGCAGTTTACTTAACTTA
CTGTTTTGAGTCCTAAACTTAGAGTTGTTAATGCTTATATATAATCTAAC
CAAAGAGTTACCCAGTAGGGTTTTAGTTTTTGAACTTTTATTTTCTTGTT
GATTATAAATCCTGATTTTGGAATCTATTGCGCAAAAGAAGTTTCATTTT
GGTTACTTAGACCTAAGATCACTTIlllllAATCCTTATTTTCTCChAGC
CCAGCAAACGTTGACTTCTGGGCAAACCTGAAAACCTGAAAATGCCACTT
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Figure 2. Alignment of the complete deduced sequence of
the open reading frames of the human and mouse Pfetl
genes. The deduced amino acid sequences of the ORFs share
91% similarity and differ by eight amino acids, one of which
is within the tetramerization domain (position 88). A high
degree of sequence similarity indicates cross-species
conservation of the PFET1 gene. Nucleotide sequence is
capitalized for the human PFET1 gene and in lower case for
the mouse PFET1 gene. Amino acid sequence is capitalized
and numbered in parentheses. Dots represent sequence
identity between human and mouse genes. Dashes represent
gaps introduced to align the sequences. An asterisk denotes
the stop codon. The tetramerization domain is underlined.
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Figure 3. Nucleotide sequence of mouse PfeIl cDNA and
its deduced amino acid sequence. Nucleotide numbers are
shown on the left and amino acid sequence numbers are
shown in parentheses on the right. The Kozak consensus
sequence is outlined in red. The tetramerization domain is
underlined. An asterisk denotes the stop codon. Putative
polyadenylation consensus sequences are shaded.
2084 AGTTTGACCAGTGTGGCCTGGAATCCAGATGGGAAACGCTTTGTGACGGG
2134 AGG:CAGCGTGG:CAGTTCTACCAGTGTGAAAAGGACGGAN\TCTTCTGG
2184 ACTCCTGGGAAGGAGTGCGAGTACAGTGCCTGTGGTGCTTGAGTGACGGG
2234 AAGACTGTGCTGGCTTCCGACACGCACCAGAGAGTCCGGGGCTACAACTT
2284 TGAGGACCTGACAGATAGAAACATAGTACAGGAAGATCATCCTATTATGT
2334 CATTTACTATTTCCAAAAATGGCCGATTAGCTTTGTTAAATGTAGCAACT
2384 CAGGGAGTTCATTTATGGGACTTGCAAGACAGAGTTTTAGTAAGGAAATA
2434 TCAAGGTGTTACCC&~GGGTTTTATACAATCCACTCGTGTTTTGGAGGCC
2484 ATAATGAAGACTTCATTGCTAGTGGCAGCGAAGATCACAAGGTTTACATC
2534 TGGCACAAACGTAGTGAACTGCCAATTGCGGAGCTCACAGGGCACACGCG
2584 CACAGTAAATTGTGTTAGCTGGAACCCACAGATTCCATCCATGATGGCCA
2634 GTGCCTCAGACGATGGCACTGTTAGAATATGGGGACCAGCACCTTTCATA
2684 GACCACCAGAATATTGAAGAGGAATGCAGTAGCATGGATAG~TGATGGCA
2734 AATTTGGAGCAGACGACTTCTGTTTAACTTAAAATTAGTCGTATTTTAAT
2784 GGCTTGGGATTTGGTGCAAACAAACATGATTGATAGCTGGACAGACATGC
2834 TCGTCATGAAAAAAAAAAAAAAAGAACCATTTTGAAGCCCGATTGGGGCC
2884 AAACATTTACACCTTGCTTCCTAGTAACCAGTTGATGAAGCGCGTCTAGA
2934 ACGTTGTTGGACACCATGTTGAATTATTCCCCATCGGTTGTGAAGAACTG
2984 TGCTACATTCAGGCTTACCCATTGAACTCAGTATATATATTTTTTCCCTC
3034 CTGCCTTTTGTCTGGTGGGACACCATTCTTGTTGCTCTTCTGTGTAATGA
3084 AGTTCAATGCTTGTTTGGAAACTTTATTTAACANTTTAAAAGGCTTGATA
3134 GGAAGAGGTCATTAATCTTGAAGAGTTNCATTTGGAAGG.~AAAATTTCC
3184 TTTCGTTTCTCCAATCTTTCCCCNTTTTTANCGTGAGATCTTTGCAGCCT
3234 TGGTNCTGGATTCTAGCCTTGCCCGTTGCGCAGTATATGCNTGATCAGAT
3284 GATAAACCAGTGAACTATGTCAAAAGCACTCTCAATATTACATTTGACAA
3334 AAAGTTTTGTACTTTTCACATAGTTGTTGCCCCGTAAAAGGGTTAACAGC
3384 ACAATTTTTTAAAIIIIIITTAAGAAGTATTTATAGGIIIIIIGTGACTT
3434 CATTTGTATACATTTGGAATCTAAP.CCAGCTTAAAAACAGTGTCCTCTGT
3484 GACTGAGATATGCAGTGTAACTGATGCTCTTCTGGAGTGCCACGTGAGAC
3534 ATGGCATGGTCAGAAACAGTGTTCAGAAGGACACGGCACAGGAAAGCCAG
3584 AGAGATACTTTCCCCTTTTTATTTTATTCCTGAAGGGACATCAGTACCTG
3634 ATACTGAAGAAATTCAAGATTCAAAAGGAAAATTTTATA CCAGT
3684 ACAGAAGATCAGCATCAGTCTAGGTTTTCAAGAAAGCTTGTTCCAAGTTC
3734 TCTGAACTTGAGGGAATCGTTTTGATGTGATCTANCANAAGTAGACATCA
3784 NAAGATAGACCTACTTTGGGAATTTATAGTGTAGTTAAATCTTAGAGGAA
3834 GTCAGCAGGCTACAAACATTTATGTAAACTGGAIIIIIIGCCTGAGTCAT
3884 TTCTCCTAATTGCCCTTAATGTCCAACATATAGGGACACTCATTTAAAGA
3934 AGATTCCTTCTCAGCTTCTCAGATGTTGCCATAATGAACCTCATTCAAAC
3984 TGGTGCTGTGGACAGTCTTTCCCTCTCCCTCCCCTTTTAGTTTACGGGAA
4034 TGTTTCCTTTATGGAAAAAAAGTGACTTGTCATTTTGAAGACCCTATATC
4084 TAACATAAGCCTGATTGATGTTCATGGTGTTTTCAACTCCATAAATTGCT
4134 GGGTCTAACCAGTCTCCCTTGAAATCCATGTTTTCCAATAGGAGATAACC
4184 AGGGTGACCACAGCTCTTGGAAGGAAAAGTGGAATTAACTCCAATGTATC
4234 CTGATGAACAACAACAACAAAAATNTGGTACAACTTGCCCTTGAGGCCAA
4284 GCCAAGTCCATAGCATTCACCATGATCATATGCCCCTCGGGATCCTGANA
4334 NAANANANAGGCTTGTACTGAGGGGTNTTCCCATTGTGGGGGTCGCAGGG
4384 AGGGAAAAGCCAGGAAGGCAGTGGTCATTNTCCCAAAGTCCACCCATCGT
4434 AAGGAGGTGACAGATCGGAGTCAGCAGATTAGTAATTCAAATGGGTAATG
4484 GAAAAGATTCCTTTAAGCTTCATTTTTCAGAGACCATCACTTTAGAAAAT
4534 CAGAGAAATCCTGTTTTGATACTTNTTAGTTAAAATAATATGTTACCGTT
4584 TATCTGGTACTTCATTTTNTTGACTAAAATTACTTTTCACTTTAAGCTTG
4634 IlllllAATTTTCATTCATAACTGTAAAAAAAAAAAAAAAAAAAAAAAAA
(45)
(30)
(75)
(15)
(60)
(90)
ACTCGCCTGGAGCGCGCGGGCGAGGCAGGCGCAGCGCACCGGGGC
:CTCGTGGGCGCACTGCTGCGCGCTCGCACCGCGCGGCTCTCAG:
GGCCGGCCGCCGCCTGAGCGCAGGGC:CCCCGATAP.GAGCCGCTG
GGGCTTCCGATCGCGACCCCGCTCCC:GCCAC:TGGCCCATCCGG
GCCACCTCTTTTTGGCC
1 atggctctggcggacagcgcccgaggattacccaacgggggcgga
MAL ADS A R G LPN G G G
45 ggcggaggtggcagcggctcgtcgtcgtcctcggcggagccgccg
G G G G S G S S S S S A E P P
90 ctcttcccggacatcgtagagctgaacgtgggagggcaggtgtat
L F P D I VEL N V G G Q v Y
gtgacccggcgctgcaccgtggtgtCCgtgcccgactcgctgctc
V T R R C T V V S V P 0 S L L
tggcgtatgttcacgcagcagcagccgcaggagCtggcccgggac
W R M F T Q Q Q P Q E L A R 0
agcaaaggccgcttctttctggaccgggacggcttcctcttCcgc
S K G R F F L D R 0 G F F F R
tacatcctggattacctgcgggacttgcagctcgtgctgcccgac
Y I L 0 Y L R 0 L Q L V L P 0 (105)
tacttcccggagcgcagccggctgcagcgcgaggccgagtacttc
Y F PER S R L Q REA E Y F (120)
gagctgccggagctcgcgcgtcgcCtcggggcgccccagcaaccc
E L PEL V R R L GAP Q Q P (135)
ggtccggggccaccgccgccgcactcgcgccgcggggtgcacaag
G P G P P P PHS R R G V H K (150)
gagggctctctgggcgatgagctgctgccgctgggctacgcagag
E G S L G 0 ELL P L G Y A E (165)
cccgagccgcaggagggcgcctcggccggggcgccttcgcccacg
PEP Q E GAS A GAP S P T (180)
ctggagctggctagccgcagcccgtccgggggcgcggcggggccc
L E LAS R S PSG G A A G P (195)
ctgctcacgccgtcccagtctttggacggcagccggcgCtCcggc
L L T P S Q S LOG S R R S G (210)
tacatcaccatcggctaccgcggcccctacaccatcgggcgcgac
Y I T I G Y R G S Y T I G R 0 (225)
gctcaggcggacgccaagttccggcgggtggcgcgcatcaccgtg
A Q A D A K F R R V A R I T V (240)
tgcggcaagacgtcgctggccaaggaggtgtttggggacaccctg
C G K T S L A K E V F GOT L (255)
aatgagagccgggaccccgaccggcccccggagcgctacacctcc
N E S R 0 P 0 R P PER Y T S (270)
cgctattacctcaagttcaacttcctagagcaggccttcgataag
R Y Y L K F NFL E Q A F 0 K (285)
ctgtccgagtcgggcttccacatggtggcgtgcaggtgcacgggc
L S E S G F H M V A C R C T G (300)
acccgcgcttttgctagcagcaccgaccagagcgaggacaagatc
T C A F ASS T 0 Q SED K (315)
tggaccagctacaccgagtacgtcttctgcagggagtga 983
W T S Y T E Y V F C R E * (327)
GCTCCCCACGCCCGCCCCTCGCCACTCCGCCGCTGGCAACAATAGCAACA
GCCTGAGTGTCAATAACGGGGTTCCCGGCGGGGCCGCCGCGGCCTCCGCC
ACCGCCGCCGCCGCCCAGGCCACCCCCGAGCTGGGCAGCAGCCTCAAGAA
GAAGAAGCGGCTCTCGCAGTCCGATGAGGATGTCATTAGGCTCATAGGAC
AGCACCTCAATGGCCTAGGGCTCAACCAGACTGTTGATCTCCTCATGCAA
GAGTCAGGATGTCGTTTAGAGCATCCTTCTGCTACCAAATTCCGAAATCA
TGTCATGGAAGGAGACTGGGATAAGGCAGAGAATGACCTG.~TGAGCTAA
AGCCTTTAGTGCATTCTCCTCACGCTATTGTGGTAAGAGGCGCACTTGAA
ATCTCTCAAACGTTGTTGGGAATAATTGTGAGGATGAAGTTTCTGCTGCT
GCAGCAGAAGTACCTGGAATACCTGGAGGACGGCAAGGTCCTGGAGGCAC
TTCAAGTTC:ACGCTGCGAACTGACGCCGTTGAAA:ACAACACCGAGCGC
ATCCATGTCCTTAGTGGGTATCTGATGTGCAGCCATGCCGAAGACCTACG
GGCAAAAGCTGAATGGGAAGGCAAGGGCACAGCGTCCCGGTCCAAACTGC
TGGACAAGCTTCAGAACTCTCCTGCGGCAGGCGGTGGAACTACAAAGGGA
TCGGTGCCTATATCACAATACCAAACTTGACAATAATCTAGATTCTGTGT
CTCTACTTATAGATCATGTTTGTAGTAGGAGGCAGTTTCCCTGTTACACT
CAACAGATACTTACAGAGCATTGTAATGAAGTGTGGTTCTGTAAATTTTC
TAATGATGGCACTAAACTAGCAACAGGATCAAAGGATACCACAGTTATCA
TATGGCAAGTTGATCCGGATACGCACCTGTTAAAACTGCTTAAAACGTTA
GAAGGACATGCGTATGGTGTCTCTTATATAGCATGGAGTCCAGATGACAG
CTATCTTGTTGCTTGTGGTCCAGATGACTGCTCTGAGCTTTGGCTTTGGA
ATGTACAGACGGGAGAATTAAGAACAAAAATGAGCCAATCTCATGfu~GAC
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Figure SA-C. Autoradiographs of Northern blots
containing 10 ug per lane of totalhuman RNAs
hybridized with radiolabeled PFETI fragments.
(A) A panel of human fetaltissues probed with
the 3'-most UTR PFETI probe (MT fragment)
demonstrates expression of a single transcriptof
-6 kb in most tissues,with highest expression in
cochlea and brain. (B) A panel of adult ("A")
and fetal ("F") RNAs probed with various
PFETI probes demonstrates high levels of
expression of a single -6 kb transcript in fetal
tissues and barely detectable levels in adult
tissues, including spinal cord, cerebrum,
cerebellum, skeletal muscle, lung and lymph
node. Similar low level expression was observed
in the other adult tissues that are not shown,
including lung, heart, kidney and liver. (C) A
panel of total RNA isolated from different
regions of the fetalbrain probed with PFETl; a
single -6 kb transcriptis detected in allsamples.
A lane of fetalcochlear RNA was included as a
positive control. For each Northern blot, a
photograph of the EtBr-stained RNA gel IS
shown. F, fetal;A, adult;Y, years; W, weeks.
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Figure 6A-C. Northern blot analysis of mouse
RNA samples hybridized with mouse Pfetl
radiolabeled fragments. (A) An adult mouse
tissue panel containing 10 ug of each sample
hybridized with a probe to the 3' end of the
ORF reveals low expression levels of a single
~6 kb transcript in adult mouse tissues. A lane
containing 10 ug of human fetal brain total
RNA is present for comparison. A, adult; M,
mouse. (B) A mouse aging brain panel
containing 20 ug of each sample hybridized
with the 3' UTR probe 1 reveals the presence
of a predominate ~6 kb transcript and two
smaller and less intense transcripts (~4 and 4.5
kb) in the embryonic and newborn stages. (C)
A mouse developmental panel containing 20 ug
of each sample hybridized with a probe to the
3' end of the ORF reveals two transcripts. The
upper transcript (~6 kb) has a higher level of
intensity between days 11.5 and 15.5 while the
lower transcripts (~4 and 4.5 kb) have a higher
level of intensity between days 6.5 and 15.5.
For each Northern blot, a photograph of the
EtBr-stained RNA gel is shown.
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Figure 7. Chromosomal localization by fluorescence in situ hybridization
(FISH) of a human PAC containing the entire PFETl gene. Human
metaphase chromosomes are counterstained with OAPI following FISH
with PAC 246J2. Arrows indicate the positions of the signals that localize
to band q21 on both chromosome 13s.
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Figure 8. Immunohistochemical staining using pfetin antibody on (A) formalin glutaraldehyde
(FG)-fixed guinea pig, (B) FG-fixed mouse, and (C) FA-fixed monkey cochleas. Arrows point
to individual cells positive for immunostaining with pfetin antibody. Positive immunostaining
is seen as the dark DAB reaction product. Dominant staining is seen in type I fibrocytes of the
cochlea. TI, 4,5 = types I, IV, and V fibrocytes; PC = pillar cell; IDC = interdental cell; ISC =
inner sulcus cell; SL = supralimbal cell; LF = limbal fibrocytes; RC = root cells; SG = spiral
ganglion cells. Each scale bar represents 100 microns.
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Figure 9. Immunohistochemical staining using pfetin antibody on formalin-fixed adult human
cochlea (A). Higher magnification views of the boxed areas are shown in correspondingly
lettered images below (B-E). Arrows point to immunostained cells. Immunostaining is present
in type I (Tl), IV (T4), and V (T5) fibrocytes. LF = limbal fibrocytes; * = extracellular matrix.
Each scale bar represents 100 microns. The images in B-E are all the same magnification.
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Figure 10. Immunostained formalin plus glutaraldehyde fixed mouse (A and B) and formalin
acetic fixed guinea pig (C) cochlea. Panel (A) shows the organ of corti, (B) the spiral limbus
and (C) areas contacting Reissner's membrane. IPC, OPC :::::inner and outer pillar cells; DT:::::
Deiters cells; ISC :::::inner sulcus cells; roc::::: interdental cells; LF :::::Iimbral fibrocytes; HC :::::
Hensen cells; SG = spiral ganglion; T5 :::::Type V fibrocytes (suprastrial cells); SL :::::
supralimbal cells. Each scale bar represents 50 microns.
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Figure 11. Pfetin immunostaining of vestibular tissue of 20-week human fetus (formalin-
fixedXA-O), guinea pig (formalin plus glutaraldehyde-fixed)(E, F), and mouse (formalin plus
glutaraldehyde-fixed)(G, 1-1). The semicircular canal shows (A) a continuous layer of staining
(arrow) in the lateral ampulla underlying the transitional cells and vestibular dark cells. (B)
Higher magnification of boxed region in (A). Arrows point to individual positive cells. (C)
Arrows indicate immunostained cells lining the lumen of the semicircular canal. (0) Higher
magnification of boxed region in (C). (E) Guinea pig posterior ampulla with arrows pointing
to immunostained cells. (F) Higher magnification of boxed region in (E). (G) Sensory
epithelium of the macula of the saccule showing the immunostained type I hair cells. Arrow
points to the unstained ciliary bundle extending from the darkly stained cuticular plate. This
and adjacent type I hair cells also show granular reaction product within their cytosol. (H)
Mouse lateral ampulla with arrows pointing to immunostained lumenal and ablumenal cells.
Arrowheads point to cuticular plate staining of type I hair cells. Asterisk indicates staining in
the connective fibrocytes underneath the sensory epithelium. Scale bars in Figures 12A, C and
E represent 100 microns; in Figures 12B, 0, F, and G 10 microns; in Figure 12 H 20 microns.
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ABSTRACT
KCTD1 2 (originally described as PFET1) was initially isolated from the Morton
human fetal cochlear cDNA library with a predominant expression in the fetal cochlea and
brain. It is a 6 kb intronless transcript and a member of the newly classified and enlarging
potassium channel tetramerization domain containing (KCTD) family containing a single
tetramerization domain (T1). Functional characterization of KCTD12 and its gene product
pfetin have been studied in zebrafish with in situt hybridization, immunohistochemsitry and
morpholino knock-down of the KCTD12 zebrafish ortholog right on (ron). In sitlu
hybridization revealed expression of ron and its encoded protein Ron in the developing
zebrafish otic vesicle (OV) and vestibular-cochlear ganglion (VCG). Immunochemical
analysis showed co-localization of Ron and an early inner ear marker Isletl (Isll) within the
VCG. Morpholino knock-down experiments showed correlation between Ron knock-down
and Isl 1 down-regulation in the VCG during early zebrafish development. Given these
observations, we postulate Ron's role as a regulator of neuronal differentiation and identity in
the developing inner ear.
KEYWORDS: PFET1, Isletl, Ron, KCTD, Vestibular-Cochlear Ganglion, TNF-alpha,
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INTRODUCTION
Previously, we reported the identification of a novel 6kb cochlear transcript, KCTD12
(gene aliases: KCTD12; Cl3orf2), using a combinatorial approach of subtractive
hybridization and differential screening of a human fetal cochlear cDNA library. KCTD12
was determined to be a predominantly fetal expressed gene with a single tetramerization (TI)
domain, encoded by a single highly GC-rich (70%) exon, and predicted to contain a full-
length ORF o 325 amino acids. Genomic location for KCTD12 was confirmed by FISH
analysis to band q21 on human chromosome 13. Immunohistochemistry with a polyclonal
antibody raised against a synthetic peptide to the KCTD12 sequence reveals expression in a
variety of cell types in human, monkey, mouse, and guinea pig cochleas and the vestibular
system, including type I vestibular hair cells (Resendes and Kuo 2004). Given its unique
preferential expression in fetal cochlea (as late as second trimester developmental age in
humans) and the presence of a voltage-gated potassium channel associated T1 tetramerization
domain in its ORF, KCTD12 was chosen for further characterization. Currently, KCTD12
maps within the vicinity of the AUNA1 locus (13q14-21), responsible for progressive
autosomal dominant auditory neuropathy in a large kindred from the United States (Kim et al.
2004).
KCTDI.2 is the 12th member of the potassium channel tetramerization domain
containing (KCTD) gene family (Marchler-Bauer et al. 2003). Although the presence of a T1
domain suggests certain functional association with potassium channels and ion transport,
familial functional characteristics for KCTD have not been established. Therefore a closer
examination of the existing family members should provide insight into deducing certain
familial functional traits. To delineate the function of the KCTD12 encoded protein pfetin in
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development, we turned to zebrafish (Danio Rerio), a vertebrate animal model for study of the
inner ear due to its ease of generation, in vivo manipulation, and many similarities to the inner
ear of higher vertebrates including humans. Expression analysis through in situ hybridization
and immunohistochemistry were pursued to provide specific localization information on the
zebrafish ortholog of KCTD12 and morpholino knock-down experiment were performed to
facilitate determnination of gene function in vivo. Through these analyses, the role of KCTD12
in the vertebrate inner ear has been further elucidated.
MATERIALS AND METHODS
Linkage Group Mapping of KCTD12 Zebrafish Orthologs
Blast analysis through the Washington University - Zebrafish Genome Resources
(http:'ztish.wustl.edu') identified two ESTs, leftover (lov) (NP_919386, wz39483.2) and
right on (ron) (wz41247.1,) that have largely been studied to date for their asymmetric
expression patterns in the habenula (Gamse et al. 2003, 2005). To confirm duplication of the
KCTD12 ortholog in the zebrafish genome, a BAC (zK24H22) containing the entire ron
genomic sequence was used to generate a biotin-labeled probe for fluorescence in situl
hybridization (FISH). Given the 75% identity match at the nucleotide level between the two
orthologs' ORF, a single probe (zK24H22) was able to identify both lov and ron. Probe
labeling and visualization were carried out using standard protocols (Lee and Smith, 2004).
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Real Time RT-PCR
Real time RT-PCR is a sensitive and quantitative tool used for determination of
relative RNA expression levels in a gene of interest. Wild-type AB zebrafish embryos were
grown until various developmental stages (12, 24, 36, 48, 72 and 96 hours post fertilization).
Total RNA was extracted using Trizol and treated with DNAse. RT-PCR reaction was carried
out using SuperScript One-Step RT-PCR with a Platinum Taq kit (Invitrogen, Carlsbad, CA).
Primers and probes for lov (NP_919386), ron (wz41247.1) and the housekeeping gene
bactini (NM131031) were designed with PRIMEREXPRESS software (Applied Biosystem,
Foster City, CA). PCR primers used were: upper 5'AAGTCAGATTCAAGGGCCTATTTG3'
and lower: 5'TGCAGTGTTCGGAT- GAAGCA3' fotbr lov; upper:
5'GAGGCAGAATATTTCCAACTTCAAG3' and lower: 5'TCTGGCAAACCTCCTCGCT3'
for ron; and upper: 5'AGGTCATCACCATCGG-CAAT3' and lower:
5'ATGAAGTGCGACGTGGACATC 3' for bactin]. Probes used were
5'C'CCAGAT(-iTGTTTTGTACTCGTTATTCTTTATGCA3' for lov; 5'AGCGCC-
TGAAACCTGCGGTCAGTAAG3' for ron; and 5'CTTCCAGCCTTCCTTCCTGGGT-
ATGGAA3' for hactin . Primers were tested using conventional PCR and shown to amplify a
single band of approximately 100 bp without production of primer dimers. Real-time PCR,
which quantifies the amount of product after each cycle, was carried out on each cDNA
sample using an i-cycler (BioRad, Hercules, CA) with Taqman probe. Reactions were heated
to 50°C for 15 minutes followed by 95°C for 3.5 minutes. Subsequently, reactions proceeded
through 45 cycles at 95°C for 15 seconds and 60°C for 1 minute. The fluorescence level was
determined after each cycle, allowing detection of the log phase of amplification. -cycler
software was used to define the cycle in which each sample attained the threshold value of
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fluorescence. For a negative control, Taq DNA polymerase was substituted for reverse
transcriptase. All samples were assessed in duplicate. Lov and ron mRNA level are expressed
as fold increase adjusted for genomic contamination and normalized to bactini.
Developmental In Situ Hybridization
Zebrafish (Danio rerio) (strain wild-type AB) were kept on a 14/10 hour light/dark
cycle according to standard procedures (Westerfield, 1994). Embryos were collected from
pairvise timed matings and raised at 28.5°C until the appropriate stage (12, 24, 36, 48, 72,
and 96 hours) and then fixed by incubation overnight in 4% paraformaldehyde at
4°C. Embryo medium was supplemented with -phenyl-2-thiourea (PTU, 0.003%) prior to
24 hours post fertilization to prevent accumulation of pigment. After fixation, embryos were
dehydrated and stored at -20°C in 100% methanol prior to in situ hybridization. Nucleotides
spanning the ORF of zebrafish lov and ron were amplified and cloned into a vector derived
fromn pCRII-TOPO (Invitrogen). To generate digoxigenin (DIG)-labeled antisense probes, the
DNA plasmid was linearized with HindlII or Xho , followed by transcription using SP6/T7
polymerase and DIG RNA labeling mix (Roche, Indianapolis, IN). In situl hybridization was
then performed according to the high resolution whole-mount in situ hybridization protocol
(http:,1 zfin.or,'zf info,'ztbook/chapt9/9.82.htnll). The labeling reaction was monitored under
a dissecting microscope and the reaction stopped with X PBS at pH 5.5. For image recording,
embryos were mounted in methyl cellulose for whole mount or embedded in JB-4 resin
(Polysciences, Warrington, PA) and sectioned between 4 to 6 micron thicknesses. Images
were recorded using a Zeiss Axiocam digital camera (Carl Zeiss, Oberkochen, Germany) and
Photoshop software (Adobe, San Jose, CA).
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Morpholino Knockdown and Zebrafish Immunohistochemsitry
Morpholino oligonucleotide (MO) knock-downs were performed as described
previously (Malicki et al., 2002). MOs are basically synthetic DNA analogues that contain a
neutral charged backbone in which the deoxyribose sugar moieties are replaced with
morpholino (hydro-l, 4-oxaine) rings. The stability, nuclease-resistance, efficacy, long-term
activity, water-solubility, low toxicity and specificity of MOs make them a most ideal gene
knockdown reagent. It functions by specific binding to its selected target site to block access
of cell components to that target site. MOs can be used to knock down expression of many
target genes by sterically blocking the translation initiation complex or modifying and
controlling normal splicing events by blocking sites involved in splicing pre-mRNA (Gene
Tools, Philomath, OR).
For ron, two custom oligonucleotides were used with one targeting the 5' untranslated
region (ron 5'UTR morpholino) and one targeting the open reading frame region (ron ATG
morpholino): ron5'UTR, 5'-AGACCTCCAGTGCAATCACAGAACT-3' and ronATG, 5'-
GCGCGAGTCTTATCCATCTTTGCAC-3'. Specificity was confirmed by
immunofluorescence labeling of frozen tissue sections of both control and anti-ron
morpholino-injected zebrafish embryos. After the injection of morpholinos, embryos were
sacrificed at specified time points and prepared for frozen sections for immunohistochemical
analysis with antibody staining (Malicki, 1999; Pujic and Malicki, 2001). The following
primary antibodies and dilutions were used: mouse anti-acetylated alpha-tubulin (1:500,
Sigma, St. Louis, MO); mouse anti Islet-1/39.4D5 (1:500, Developmental Studies Hybridoma
Bank, Iowa City, IA); rabbit anti-Ron (1:500, gift from Dr. Gamse). For frozen section
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immunohistochemistry analysis, tissue sections were blocked in 10% goat serum, 0.5% Triton
X-100 in PBST for 1 hr and incubated overnight in primary antibody at 4°C and followed by
Alexa 488-conjugated secondary antibody at room temperature for 3 hours. Following three 5
minutes washes in PBST, sections were viewed using a Leica confocal microscope with a
Leica HCX APO L40X lens.
RESULTS
Domain Analysis
Blast analysis revealed KCTD12 to be a member of the KCTD (potassium channel
tetramerization domain containing protein) family. Presently, this family consists of 19
members (Table ) with heterogeneous chromosomal locations, coding regions (225 to 950
amino acids), numbers of exons (1 to 18), and GC content in the ORFs (40 to 70%). Thus far,
the lack of any predicted transmembrane domains and the presence of a single tetramerization
domain are the salient features shared by members of the KCTD family. Most members of
the KCTD family have been recently identified and sequenced. Besides KCTD12, only a few
other members have been studied: KCTD1O is a novel PDIPl-related protein that interacts
with proliferating cell nuclear antigen and DNA polymerase delta (Zhou et al. 2005),
KCTDll is a suppressor of Hedgehog signaling (Di Marcotullio et al. 2004), KCTD3 as an
antigen of renal cell carcinoma (Scanlan et al. 1999), and KCTD13 is a distal target of TNF-
alpha activation and a link between cytokine activation and DNA replication (He et al. 2001).
As more detailed studies on members of KCTD family become available, further potential
unifying functional speculation will be possible.
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Table 1. KCTD Family
Predicted Number of
KCTD ORF in Chromosomal predicted ORF
family amino acid Location exons GC content (%)
KCTD 257 18qg11.2 5 43
KCTD2 263 17q25.1 6 55
KCTD3 295 lq41 18 42
KCTD4 259 13q 14.12 1 40
KCTD5 234 16p 13.3 6 59
KCTD6 237 3pl4.3 3 45
KCT1)D7 289 7q11.21 4 60
KCTD)8 473 4pl3 2 59
KCTD9 389 8p21.2 11 43
KCTDIO 313 12q24.11 7 54
KCTDI 232 17pl3. 1 65
KCTD12 235 13q21 1 70
KCTD13 329 16pl1.2 6 62
KCTDI4 225 lq14.1 2 54
KCTD15 283 19q13.11 7 63
KCTD16 428 5q31.3 4 40
KCTD 7 314 22ql12.3 9 64
KCTD18 426 2q33.1 7 51
KCTD19 950 16q22.1 16 53
Analysis of KCTD12 in its Zebrafish Orthologs, Leftover and Right on
Zebrafish is a good vertebrate animal model for genetic studies because of its high
reproductive rate, easy access to embryos of all stages due to external fertilization and
transparent development. The zebrafish inner ear also has many similarities to that of
mammals with three semicircular canals and a utricle for vestibular function. The saccule and
lagena are used for sound detection. Since the embryos are optically transparent, its inner ear
and any subsequent staining from experimentation can be easily observed in early
developmental stages. As pigment develops in later stages, 1-phenyl-2-thiourea (PTU) can be
added to suppress pigment formation. Over a dozen genes have been studied in zebrafish that
are pathogenetic for specific defects in the development of the ear (Whitfield et al. 2002).
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Linkage Group Mapping of Leftover and Right on
Linkage group mapping showed BAC probe (zK24H22) localization to zebrafish linkage
group 8 and 1 only (Fig. 1).
Sequence analysis
Blast analysis has shown lov and ron to be 75% identical at the nucleotide level within
the ORF and share little sequence similarity outside of the ORF. These two KCTD12
orthologs are also 69% identical at the amino acid level with a protein prediction of the lov
ORF of 288 amino acids and the ron ORF of 271 amino acids. Unlike KCTD12, the GC
content of lov and ron ORF each at 53% is not considered to be particularly GC-rich. Similar
to KCTD12, the tetramerization domain is highly conserved and no transmembrane domains
are predicted by TMpred.
Real-Time RT-PCR
Taqmarn Real-Time RT-PCR revealed the relative RNA expression level of two
zebrafish KCTD12 orthologs (ov and ron) between developmental stages 12 to 156 hours
post fertilization (hpf) (Fig. 2). Expression of these two zebrafish orthologs followed almost
an identical expression pattern with an initial peak of expression at 19 hpf and then leveling
off after 36 hpf. Several important auditory developmental events occur in this time frame: at
13-14 hours the otic placode (precursor to otic vesicle) becomes visible, at -18.5 hours the
otic vesicles form, at 22 hours the initiation of formation of the statoacoustic ganglion occurs,
at 24 hours hair cells start to differentiate, and at 48 hours the semicircular canals first appear
(ZFIN, http:/,'/zfin.org/zf info/,'anatomy/dict/ear/ear.html). Correlations between the time and
75
intensity of RNA expression could provide valuable insight into possible roles of lov and ron
in auditory development.
Zebrafish In Situ Hybridization
Whole-Mount In Situ Hybridization Studies
Based on the RNA expression level of lov and ron from real-time RT-PCR, we chose
to concentrate on establishing the otic placode and vesicle expression pattern of these two
zebrafish KCTD12 orthologs between developmental stages 12 to 96 hpf (Fig. 3). At 12 hpf
(data not shown), no significant expression pattern other than similar diffused staining along
the entire length of embryo were observed for both lov and ron riboprobes. By 24 hpf,
expression patterns between the two probes began to diverge. The majority of lov staining was
located at the branchial arches. Distinct ron staining was observed at the pectoral fin bud and
otic vesicles in addition to branchial arches while diffuse signals appeared across regions of
the midbrain and hindbrain. At 48 hpf, both riboprobes detected transcript at the pectoral fin
bud, branchial arches and yolk syncytial layer. Diffuse staining remained at the midbrain,
hindbrain, and the heart. Individually, distinct signals were observed in the left habenula for
lov, and otic vesicle and pancreas for ron. From 72 hpf on, the difference in expression
patterns of lov and ron riboprobes became more apparent. Detailed expression of lov in the
brain has been described in detailed previously (Games at al. 2003), and consistent with this
report, lov seemed to be heavily concentrated in the left habenula in the forebrain region.
Additional lov expression was observed in the heart whereas signals from ron were distributed
over the entire cephalic region with some concentration of signals at the habenular and
interpeduncular nucleus (IPN) of the midbrain. Faint staining was observed in a layer of cells
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inside the eye. No visibly significant signal from either probe was observed near the OV
region.
Tissue In Situ Hybridization Studies
Based on the expression pattern of lov and ron riboprobes in the whole-mount in situ
hybridization studies, we decided to confirm otic vesicle expression by sectioning regions of
whole-mount embryos stages 24 and 72 hpf. Consistent with the whole-mount findings, lov
antisense probe staining was negative in the otic regions between 24 and 48 hpf (data not
shown). For the ron probe at 24 hpf, staining extended from within the ventral surface of the
otocyst epithilum medially out toward the notochord along the lateral edge of the hindbrain.
By 36 hpf, ron seemed to be concentrated at the ventral medial edge of the OV where newly
formed vestibular-cochlear ganglion (VCG) cells usually reside at this stage. At 48 hpf, ron
message had formed into a compact mass localizing at the medial edge of the otic vesicle (Fig.
4). By 72 hpf, this expression pattern had shifted more medially, further away from the otic
region and became less intense (data not shown). No signals were detected in the OV from the
ron sense probe.
Right on Morpholino Experiments
Expression pattern of Ron and Isll in the Otic Vesicle
In control morpholino-injected embryos, expression of Ron and Isll at 48 hpf and 75
hpf followed a similar pattern. Expression of both proteins preceded the anterior start of the
otic vesicle (OV) continuing through the anterior macula, followed by gradual diminution
upon entering the posterior macula and finally terminating near the posterior edge of the OV.
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From the dorsal view, signals from Ron and Isll antibody co-localized to the medial edge of
the OV (Fig. 5, s ) before the anterior start of the OV. Gradual medial expansion of Ron
followed before reaching the anterior and posterior macular junction (s5) and then retreating
more laterally and closer to the OV than Isl 1. Expression of Ron and Isl 1 was at its minimum
upon reaching the posterior edge of the OV (s7). The lateral view showed clustering of Ron
and Isll expression as well. Before entering the OV, Ron expression was slightly more dorsal
and overlapped with Isll near the region where the OV was about to emerge (Fig. 5, s ).
Upon entering the anterior region of the OV, both Ron and Isl 1 remained at the same position
centered near the ventral side of the OV until after entering the posterior macula (Fig. 5, s6)
where the range of expression decreased dramatically. Images captured from the
immunohistochemistry staining revealed the majority of Ron and Isll signals to be localized
in the vestibular-cochlear ganglion (VCG). The two protein signals consistently clustered
together in circular patterns symmetrically along the medial edge of the OV. Sparse Isll
expression was noted in a small population of neurons at the center of the myelencephalon
(see white *) for zebrafish at 48 hpf. Similar expression of Ron was observed as well at 75 hpf
alongside Isll. In addition, Isll expression was observed in a cluster of neurons located
directly medial to the dorsal arotic root and below the VCG (data not shown). For the anti-ron
morpholino, there was a complete knockdown of Ron and significant reduction of IsllI
expression in the VCG. In the central region of the myelencephalon, Isll and Ron were no
longer detectable. Isll expression was retained in neurons positioned between the dorsal aortic
root and VCG at 75 hpf (data not shown).
In summary, co-localization of Ron and Isll began before the anterior edge of the OV and
then decreased in intensity and distribution upon reaching the posterior macula. The anti-ron
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morpholino revealed a dramatic knock-down of Ron accompanied by a significant decrease in
Isl in the VCG.
DISCUSSION
The KCTD Family
KCTD12 is a member of the growing family of potassium channel tetramerization
domain-containing genes, recently classified as KCTD and consisting of 19 members.
Although all family members possess a single tetramerization domain (T1), the lack of any
transmembrane domains excludes KCTD gene products from functioning as classical
potassium channels. Phylogenetic mapping of KCTD members confirms that KCTD gene
products branch off from the classical potassium channels like the potassium voltage-gated
channel shaker-related (KCNA), Shab-related (KCNB), Shaw-related (KCNC) and Shal-
related (KCND) subfamilies (Fig. 6). Out of the 19 member family, only four other members
of KCTD family (3, 0, 11 and 13) have been characterized in addition to KCTD12. Therefore,
little is known yet about the functional significance of this KCTD family. However, based on
information currently available, there appears to be some emerging similarities between
KCTD 3 and 10-13.
KCTDI0 and KCTD13 are also members of the PDIP1 family (polymerase delta-
interacting protein 1). Although they possess different expression profiles with KCTD10
mRNA mainly expressed in the lung and KCTD13 in the kidney and liver, their expression is
inducible by TNF-alpha (Zhou et al. 2005, He et al. 2001). KCTD10 and 13 could possibly
play a role in TNF-alpha induced DNA replication/repair by interacting with PCNA and
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enzymes such as polymerase 6 that is involved in DNA replication/repair pathways (Zhou et
al. 2005). Similar to KCTD10 and KCTD13, pfetin is also involved in the TNF-alpha pathway
by interacting directly with one of TNF-alpha's primary surface receptors, TNFRSF1B
(described in Chapter 3 of this thesis). Further experimentation is necessary to determine
whether pfetin's expression is also inducible by TNF-alpha.
Akin to KCTD12, expression of REN/KCTD1l is also developmentally regulated in
the brain. REN had been proposed to be a novel component of the neurogenic signaling
cascade. REN inhibition impairs expression of neurogenin-1 and NeuroD which are members
of the bHLH family of transcription factors important for neuronal development and survival
(Gallo et al. 2002). Coincidently, knock-out studies from mice genetically deficient in TNF
receptors (TNFRSF1A and B) showed increased neuronal vulnerability to excitotoxic and
oxidative insults, suggesting a neuroprotective function for both TNF-apha and its receptors
(Bruce et al. 1996). In addition, REN may also serve as both a marker and a regulator of
neuronal differentiation (Gallo et al. 2002). Data from our morpholino studies suggest that
suppression of Ron results in the near complete inhibition of Isll expression in the otic vesicle,
a marker for newly differentiated neurons (Korzh et al. 1993). Perhaps similar to REN, pfetin/
KCTD12/Ron could potentially serve as a regulator of neuronal differentiation in addition to
being a component in some TNF signaling pathway involving neuronal protection and
survival.
Ron and Isli's Role in the Inner Ear
Expression analysis via whole-mount in situ hybridization reveals distinct labeling of
the zebrafish OV by the anti-ron probe. In situ sections and immunohistochemical analysis
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on zebrafish frozen sections confirm the expression of both ron and its gene product in the
VCG.
Initial characterization of the anti-ron morpholino injection suggests suppression of
Ron may down-regulate expression of Isl 1 mostly in the zebrafish VCG. With Isl 1 commonly
serving as a marker for newly differentiated neurons, the implication is that Isll suppression
(regulated by Ron) could possibility lead to improper neuronal differentiation potentially
jeopardizing the survival of neurons in the VCG. To understand the effect of Ron on VCG,
the role of Isll in inner ear neuronal development warrants examination.
Isll(alias: Lim-homeodomain protein Isletl, islet-l) is a member of the LIM-HD
transcription factors that function as key regulators in developmental pathways such as
specification of neuronal cell fate in the vertebrate nervous system (Bachy et al. 2001). Isll
was initially identified as a protein binding to the rat insulin gene enhancer (Karlsson 1990). It
is expressed in a variety of tissues including thyroid, pituitary, kidney, spinal cord, heart,
brain and inner ear. Mice lacking Isll do not survive past E1 1.5. Loss of Isll perturbs the
generation of motor neurons, and differentiation of many of the cell types that normally
express the protein, including sensory neurons of dorsal root and cranial sensory ganglia and
cells of the endocrine pancreas (Pfaff et al. 1996)
The functional domains of LIM-HD transcription factors consisting of two tandem
LIM domains followed by a homeodomain (HD) are capable of forming tetrameric and
hexameric interactions with other transcriptional regulators and creating an array of
transcriptional regulating complexes. It is perhaps this flexibility that enables them to regulate
transcription in a tissue-specific manner and participate in a variety of developmental events
including establishing neuronal subtype identity (Hobert and Westphal 2000, Shirasaki and
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Pfaff 2002). In regard to this particular role, LIM-HD may partner with the basic helix-loop-
helix (bHLH) transcription factors in the determination of neural identity.
During the multistep process of neurogenesis, bHLH proteins have traditionally been
classified as proneural factors involved in activation of neurogenesis during which neuronal
precursor cells gradually adopt neuronal characteristics and become committed to neuronal
lineage; the LIM-HD proteins would act specifically on postmitotic neuronal cell subtype
identity after neuronal cells have undergone terminal differentiation and on their way to
becoming more mature neurons. And these two processes, originally thought to happen at
different stages of neurogenesis, were shown to work in a synchronous fashion as in the case
of motor neuron subtype identity where bHLH transcription factors NeuroM and E47
cooperate with LIM-HD complexes (NLI, Isll and Lhx3) to specify motor neuron subtype
identity (Lee and Pfaff 2003).
New evidence suggests that this form of cooperation might also take place in the
determination of inner ear neuronal lineages. In the developing chicken inner ear, islet-1 is
expressed in cells of the ventral part of the otic placode where auditory and vestibular neurons
originate, demonstrating islet-1 as one of the earliest markers of inner ear neural precursors
(Li et al. 2004). Similar expression was shown within the region of the mouse otocyst that
gives rise to both the auditory sensory organ (the organ of Corti) and the sensory ganglion
neurons (SG) increasing the likelihood of Isll as a common step in the early development of
both sets of cells in inner ear development (Radde-Gallwitz et al. 2004). In cells giving rise to
the neuronal lineage, Isll expression co-localized with NeuroD, an inner ear neuronal marker
expressed during early development. Subsequent expression showed maintenance of Isll
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expression in the neuronal lineage and down-regulation in the sensory lineage upon initiation
of hair cell differentiation.
NeruoD as a potent neuronal differentiation factor is vital for survival of inner ear
sensory neurons during differentiation. Mice lacking NeuroD protein exhibit no auditory
evoked potentials, reflecting a profound deafness due to failure of inner ear sensory neuron
survival during differentiation in development. (Kim at al. 2001). Mice lacking Isll do not
survive past El 1.5. However if Isll and NeuroD were truly to cooperate in the confirmation
of inner ear-specific neuronal or sensory competency/identities, then Isll would be as vital to
the survival of inner ear neurons as NeuroD making pfetin/Ron a potentially important
regulator of inner ear neurons.
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Figure 1. FISH of zebrafish metaphase chromosomes for localization of leftover (A) and right
on (B). A. Centromeric probe to linkage group 8, zCI03G04 (green), and BAC probe,
zK24H22 (red), co-localize to the same zebrafish linkage group. B. Centromeric probe to
linkage group 1, zC00206 (green), and BAC probe, zK24H22 (red/orange), co-localize
(yellow) to the same zebrafish linkage group.
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Figure 5. Expression pattern of Ron and Isll in the otic vesicle. Two schematic diagrams are
presented detailing the expression pattern of Ron and Isll in the OV around 48 hpf, one dorsal
view and the other lateral view. Gray vertical columns represent 12-14ptm thick serial
sections from morpholino-injected embryos stained with Ron and Isll antibody, covering the
OV region. Columns are labeled as sections one through seven (sl-s7) from anterior to
posterior. Ron antibody is visualized in green and Isl l in red. The expression pattern of Ron
and Isll is represented on either side of each column denoting expression within the same
section. Corresponding immunohisto-section images are listed below for reference with
control morpholino embryo sections on the top row and ron morpholino embryos on the
bottom. All images are given at the same magnification with the scale bar denoting 50pm.
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Figure 6. Phylogenetic tree of KCTD family members. Multiple alignments of complete
amino acid sequence of human KCTD proteins were performed using ClustalX 1.83 and the
resulting tree was visualized using NJplot. Four classical potassium channel proteins (KCNA1,
KCNB 1, KCNC 1, KCND 1) were used as a reference. Branch length is denoted in the scale
bar.
93
r% k, ill,, I
CHAPTER 4
94
Genomic and Proteomic Characterization of KCTD12 and Pfetin
Sharon F. Kuol, Weining Lu2'3, Chinweike Ukomadu 2'3, Arti Pandya 4 , Walter E. Nance4 ,
Cynthia C. Morton 3' 5
l)Speech and Hearing Bioscience and Technology, Harvard-MIT Division of Health Sciences and
Technology, Boston, MA; 2)Department of Medicine, Brigham and Women's Hospital and 3)
Harvard Medical School, Boston, MA; 4)Department of Human Genetics, Medical College of
Virginia, Virginia Commonwealth University, Richmond, VA; 5)Departments of Ob/Gyn and
Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
ACKNOWLEDGMENTS
We thank Dr. Zheng-Yi Chen and MingQian Huang for performing the GeneChip analysis
and Drs. Marco Ramoni and Gil Alterovitz for their assistance with Human Massome
Database and Ingenuity System Analysis.
This work was supported by the NIH Grants DC03402 (C.C.M.), and T32 DC0019 (S.F.K.).
95
ABSTRACT
KCTD12, a member of KCTD gene family, was identified as a 6 kb cochlear transcript
containing a single exon with a particularly GC-rich ORF. Previous in situ hybridization and
immunohistochemical expression studies in revealed localization of KCTD12 and its gene
product pfetin in the vestibular-cochlear ganglion of zebrafish otic vesicle, and a variety of
cell types in the human, mouse and guinea pig cochlea. In this study, further characterization
of KCTD12 and its gene product pfetin is detailed through mutation screening of the GC-rich
KCTD12 in a series of DNAs from multiplex kindreds with hearing loss, gene expression
profiling using GeneChip technology, a database search for protein interaction and
immunoprecipitation for pfetin binding profile. Although, the screen of 88 individuals with an
increased likelihood of genetic etiology for hearing loss revealed no mutations within the
ORF of KCTD12, the protein interaction search defined two major pfetin binding partners,
TNFRSF1 B and RelA, both belonging to the TNF-a/NF-KB signal transduction pathway,
suggesting potential pfetin involvement in this signal cascade.
Keywords: KCTD 12, pfetin, TNF-alpha/NF- K B, TNFRSF 1 B, RelA
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INTRODUCTION
KCTD12 was previously characterized as a predominantly fetal cochlear transcript
with expression spanning the auditory systems of human, mouse, guinea pig and zebrafish.
KCTD12 belongs to a family of KCTD genes all containing a single the potassium channel
tetramerization (T 1) domain. To date, this T 1 domain, however, has provided little
information on the actual function of this gene family. In addition, the ORF of KCTD12 is
particularly GC rich (70%) which is of note as CpG dinucleotides have the highest mutation
rate in humans due to deamination (Ducan and Miller, 1980) and making it worthwhile to
pursue a mutation screen in the KCTD12 ORF in human populations susceptible to genetic
hearing loss.
Advances in both genomic and proteomic technologies have opened new means for
the study of hearing and deafness associated genes. Microarray technologies can be used to
rapidly determine the expression pattern of tens of thousands of genes from the inner ear. The
derived expression profiles may reveal genes with similar or differential expression patterns,
and analysis of such gene clusters may help infer underlying functional pathways (Corey and
Chen, 2002). In addition, technologies are available for large scale protein-protein interaction
studies involving the two-hybrid system, co-purification of affinity tagged complexes coupled
with mass spectrometry protein identification, and protein microarrays (de Hoog and Mann,
2004). One way to deduce a protein's function is to identify its interacting partners, because
proteins interacting with one another are often involved in the same cellular processes.
With advances in the automation of genomic and proteomic technologies such as
automated sequencing, microarrays, and mass spectrometry, an enormous amount of data
have been generated available in public databases. This rapid generation of data has spurred
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advancements in computational methods to keep pace with analysis of this rapid expansion of
new information and full integration with existing knowledge. Many bioinfomatic tools are
available and are under continues development to access and interpret expression patterns,
protein interactions, signaling and molecular pathways (123 Genomics website,
http:,/wvw. 123 glenomics.com/). Genomic and proteomic information already available in
public databases is combined herein with bench-top experimental data to investigate the
expression pattern, interaction partners and functional pathways of KCTD12 and its gene
product pfetin.
MATERIALS AND METHODS
Mutation Screening of Deafness Individuals from Multiplex Kindreds
Genomic DNAs from a panel of 88 multiplex kindreds were obtained from Dr. Arti
Pandya (Medical College of Virginia, Virginia Commonwealth University). Given the high
GC content (i.e., 70%) of the KCTD12 ORF, the GC-RICH PCR System from Roche Applied
Science (Indianapolis, IN) was used for amplification of the target region (-1 kb containing
the entire KCTD12 OREF). The following primers and PCR conditions were used: upper (5'-
CGGTTGCAGCTCCTGAGT-3') and lower (5'-GTAATCATCT CTCGGGCAGG-3');
initial denaturation at 95°C for 3 minutes; amplification by 15 cycles of 95°C for 30 seconds,
62°C for 30 seconds, and 72°C for 56 seconds, 24 cycles of 95°C for 30 seconds, 62°C for 30
seconds, and 72°C for 60 seconds; and final extension at 72°C for 7 minutes. PCR products
were gel purified, sequenced and compared against the wild type KCTD12 gene sequence
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using Blast 2 Sequences software from NCBI
(http //ww w.ncbi.nl m.nih.gov/blast/b 12 seq/wblast2.c ci).
Affymetrix Chip and Ingenuity System Analysis
GeneChip Microarray
Microarray technology offers a fast and efficient approach to study gene expression
and interaction. It can be used in cross-tissue comparisons for identification of genes with
unique expression patterns, and cluster analysis to identify genes of similar expression.
Coepxression can be suggestive of functional pathways, identifying interactions amongst
known or novel genes. There are different forms of microarray technology, but they are all
based on the general principle of a massively parallel analysis: immobilize multiple targets
(e.g., cDNAs, oligonucleotides, tissues) on the surface of a solid support, apply a sample (e.g.,
cDNA, DNA, antibody) to the targets and quantify all signals.
Dr. Zheng-Yi Chen's lab has done extensive expression analysis of cochlear
transcripts using both human and mouse Affymetrix GeneChip microarrays, human U95 and
mouse MOE430 (Affymetrix, Santa Clara, CA). Briefly, mouse utricles of developmental
stages El0.5 to P12 were dissected and RNA extracted, followed by cDNA and cRNA
synthesis, and then hybridization of fragmented cRNA to individual GeneChip. Subsequent
data analysis was performed using GeneChip Analysis Suite V3.0 (Chen and Corey, 2002).
One probe set, 1434881_sat matching to the 3' region of the KCTD12/KctdJ2 brain transcript
(gi 47578122 and gi26082764), was confirmed to be on mouse MOE430 GeneChip array.
Utilizing Dr. Chen's database, we sought to identify genes co-regulated with KCTD12.
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Ingenuity Software Analysis
The data output from the GeneChip analysis was further analyzed through the use of
Ingenuity Pathways Analysis (Ingenuity Systems, www.ingenuity.com) to seek out potential
mechanisms and functional pathways associated with KCTD12 expression. One
representation of the data analysis output is in the form of a network graph. A network/My
Pathways is a graphical representation of the molecular relationships between genes/gene
products. Genes or gene products are represented as nodes, and the biological relationship
between two nodes is represented as an edge (line). All edges are supported by at least one
reference from the literature, from a textbook, or from canonical information stored in the
Ingenuity Pathways Knowledge Base. Human, mouse, and rat orthologs of a gene are stored
as separate objects in the Ingenuity Pathways Knowledge Base, but are represented as a single
node in the network. Nodes are displayed using various shapes that represent different
functional classes of the gene product.
Immunoprecipitation (IP)
KCTD12 Expression Construct, Cell Culture and Cell Transfection
Human KCTD12 cDNA (GenBank Accession No. AF359381) containing its entire
protein coding region (327 amino acid residues) was cloned into a modified form of pcDNA3
(Invitrogen, Carlsbad, CA) that permits expression of polypeptides with three C-terminal
hemagglutinin (HA) tags. COS7 (African green monkey kidney) cells were cultured in
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum
(FCS), 100 units of penicillin, and 100 g of streptomycin in 60 mm dishes (for
immunoprecipitation analysis or Permanox Lab-Tek chamber slides (Nalge Nunc, Naperville,
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IL) (for immunocytochemistry). Cells were transiently transfected in the absence of
antibiotics with the KCTD12 HA-tagged construct using Lipofectamine 2000 transfection
reagent according to the manufacturer's protocols (Invitrogen). The negative control for
transfection experiment was performed without addition of the KCTD12 construct.
Immunoprecipitations and 35S]Methionine Labeling
An [35 S]methionine labeling immunoprecipitation reaction was performed prior to the
large scale non-radioactive IP reaction to estimate the size of pfetin binding aggregates. For
[35S]methionine labeling, the radioactive isotope [35S]methionine was obtained from
PerkinElmer Life Sciences (Boston, MA). Once cells reached 90% confluency, medium was
removed and cells were washed twice in phosphate-buffered saline prior to incubation in
methionine-free medium for one hour. Cells were labeled for four hours in methionine-free
medium, supplemented with 5% dialyzed fetal calf serum, 25 tCi/ml [35S]methionine
(specific activity, 1175 Ci/mmol). Proteins were extracted with lysis buffer as above and
separated in precast Tris-Bis gradient gels (Invitrogen, Carlsbad, CA). For the subsequent
non-radioactive IP reaction, transfected cells were treated with lysis buffer supplemented with
50 mM NaF and 1 mM Na3V04. Cell lysates were immunoprecipitated with anti-HA bound to
beads (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) for one hour. Beads were washed
three to five times in lysis buffer, followed by solubilization of adsorbed proteins with SDS-
PAGE loading buffer with P3-mercaptoethanol (-ME) at 95-100°C for five minutes and then
separated by 10% SDS-polyacrylamide gel electrophoresis. After silver staining the gel, gel
bands present only in the positive transfection lane were excised and sent for sequencing by
the Taplin Biological Mass Spectrometry Facility (Harvard Medical School, Boston, MA).
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Human Massome Database
The Human Massome of protein interactions is a newly developed public database
(wwvw.chip.orgproteomics/massome.html) containing a network of over 134,000 protein
interactions integrated from multiple existing sources in a non-redundant manner. They are
stored in a common format, and can be presented in various forms for analysis. This database
seeks to combine the strengths of the two main approaches used in proteomics (mass-based
proteomics and interaction based proteomics) to create a better protein interaction database.
The interactions are searchable by the masses of the interaction participants (including both
cleavage products and mutant proteins). It also facilitates protein identification for many mass
spectrometry technologies such as High-Throughput Mass Spectrometric Protein Complex
Identification (HMS-PCI) and SELDI (Alterovitz et al. 2005).
RESULT
Mutation Screen
To detect potential pathogenetic sequence variants within the KCTD12 ORF (given the
70/o GC-richness of the KCTD12 ORF and the associated bias towards deamination of CpG
dinucleotides as a common molecular cause of mutations in humans), a panel of DNAs was
sequenced from individuals likely to have a genetic etiology for their hearing loss. This panel,
consisting of 88 probands from multiplex sibships, was provided by Dr. Arti Pandya and
Walter Nance at Virginia Commonwealth University, Richmond, VA. This multiplex panel
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was prepared from a repository of DNA samples obtained from over 2,000 deaf probands
prescreened for common genetic etiologies of hearing disorders such as the connexins.
Primers were designed to produce a single PCR product spanning the entire KCTD12 ORF.
The ORF of all 88 probands was cloned and sequenced. Three individuals were found to have
a synonymous base change (776C>G) which does not present any new splice site. Search of
the NCB1 SNP database (http://www.ncbi.nlm.nih.gov/SNP/) revealed a single synonymous
change (215A>G). No other sequence variations were noted. As new appropriate individuals
are collected and become available from this DNA repository, they will be sequenced for
possible mutations.
Expression Profile on Affymetrix Chip and Ingenuity System Analysis
GeneChip analysis demonstrated that KCTD12, along with 38 other genes, share
similar changes of expression during mouse utricle development (Fig. 1). In this gene cluster,
elevation in expression begins around E12.5, maximum expression is reached between E17.5
and P3, followed by a steady decrease until P12 when expression is minimal. This list of 38
genes was then evaluated through the Ingenuity System for gene interaction and pathway
analysis.
Gene interactions were mapped between all members of the cluster (Fig. 2). The
largest group of gene interactions involved eight members of the 38 cluster genes. LM02
(LIM domain only 2), PF4 (chemokine (C-X-C motif) ligand 4), KDR (kinase insert domain
receptor), TGFB111 (transforming growth factor beta 1 induced transcript 1), IGFBP2
(insulin-like growth factor binding protein 2), BGN (biglycan), COL5A2 (collagen type V
alpha 2) and CSPG4 (chondroitin sulfate proteoglycan 4). This group of genes seemed to be
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centered around ITGB1 and 3 (integrin beta subunits and 3). Integrin family members are
membrane receptors involved in cell adhesion and participate in a variety of cell-surface
mediated signaling including embryogenesis, hemostasis, tissue repair, immune response and
metatastatic diffusion of tumor cells (NCBI
wNw-.ncbi.nlm i.nih.uov/entrez/query.fcgi'?db=gene). There were several smaller gene
interaction clustered around COL4A1 (collagen type IV alpha 1), SLIT2 (slit homolog 2
(Drosophila)), ABCC9 (ATP-binding cassette, sub-family C (CFTR/MRP), member 9),
C3AR! (complement component 3a receptor 1) and F13A1 (coagulation factor XIII, Al
polypeptide). However, no interactions direct or indirect were found between KCTD12 and
any other members of the 38 gene cluster and no significant match to canonical pathways was
detected.
Immunoprecipitation (IP) and Human Massome Database
Given the presence of the T domain and its association with potassium channels
which are vital for both the function and maintenance of the inner ear, it is important to
determine pfetin's binding partner and begin to delineate the exact role it plays in auditory
function.
Immunoprecipitation is one of the traditional approaches to finding interaction
partners. COS7 cells were transfected with a KCTD12 construct to express HA-tagged pfetin.
Cells were harvested and protein extract passed through an HA-conjugated column to collect
tagged pfetin and its associated proteins. IP products from both positive and negative
transfection reactions were electrophoresed in a 10% Bis-Tris gel. Four bands at 200, 70, 41,
and 35 kDa (only present in the positive transfection reaction) were excised from the gel post
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silver staining. Table I represents post sequencing results of the best-matched proteins
identified at each band size.
Table 1. Putative Interactors of Pfetin
CAD protein, fatty acid synthase, polyubiquitin
heat shock or heat shock-related protein (hsp70-1/hsp70-2), stress-70
protein, mitochondrial [Precursor] , calcium-binding mitochondrial carrier
protein Aralarl and 2 (CMCl/CMC2), ATP-dependent DNA helicase II (70
kDa subunit), 78 kDa glucose-regulated protein [Precursor], CTP synthase,
UQHUB polyubiquitin 3, Probable RNA-dependent helicase p72
41 kDa
35 kDa
pfetin, ER-associated Hsp40 co-chaperone, actin, cytoplasmic 1
pfetin, B cell receptor-associated protein BAP37, guanine nucleotide-
binding protein beta subunit 2-like 1, L-lactate dehydrogenase A and B
chain, putative deoxyribose-phosphate aldolase, ELAV-like protein 1,
mitochondrial 39S ribosomal protein L39, sideroflexin 3, calponin-2
In addition to performing IP, we took advantage of the vast information already
available in the public protein interaction databases and performed a search using the newly
developed Human Massome (www.chip.or/proteomicsmassome.htniml). It revealed two
major protein to protein interaction partners for pfetin. They are tumor necrosis factor
receptor superfamily member B (TNFRSF lB) and v-rel reticuloendotheliosis viral oncogene
homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (RelA).
TNFRSF1B (aliases: p75, TBPII, TNFBR, TNFR2, CD120b, TNFR80, TNF-R75,
p75TNFR, TNF-R-II) is a member of the TNF-receptor superfamily whose function is closely
associated with tumor necrosis factor (TNF) superfamily member 2 (aliases: TNF-a DIF,
TNFA, TNFSF2). Information from Entrez Gene, NCBI's database for gene-specific
information (www.ncbi .nlm.nih. cov/entrez/query.fcgi?db=gene), indicates that TNF-ca
encodes a multifunctional proinflammatory cytokine that functions through its receptors
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200 kDa
70 kDa
TNFRSF1A and TNFRSF1B in a variety of processes such as cell proliferation,
differentiation, apoptosis, lipid metabolism, and coagulation. This cytokine has been
implicated in a variety of diseases, including autoimmune diseases, insulin resistance, and
cancer.
RelA (aliases: p65, NFKB3) is one of the five structurally related subunits that make
up the NF-kappa B (NF-KB) family of transcription factors. Together, these subunits form
various homodimeric and heterodimeric combinations to create NFKB complexes that
function as transcription regulators (activators and repressors) in multiple cellular processes
such as inflammation, cell cycle regulation, apoptosis and oncogenesis (Arlt and Schafer
2002). Other family members include NF-KB 1/p5 0 , NF-KB2/p52, RelB and c-Rel with
p50:p65 (RelA) being the most abundant of the NF-KB complexes (Ghosh et al. 1998)
DISCUSSION
Expression analysis using the Affymetrix mouse genome array revealed a
developmental regulation of KCTD12 in the mouse utricle with peak expression centering
between embryonic day 17.5 and postnatal day 3, along with 38 other genes in the cluster.
Unfortunately, gene cluster analysis did not reveal any interaction between KCTD12 and any
other members of the cluster. However, interactions mapped here were based on research data
published prior to June 2005 (date of gene cluster analysis). Therefore, it is possible that as
more and more data become available in the public domain and new connections determined,
it will be possible in the near future to delineate the functional significance of this cluster of
genes with similar expression regulation in the mouse developing utricle.
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A search for protein interaction using Human Massome with pfetin identified
TNFRSF1B, one of TNF-alpha's major receptor and RelA, a member of the NF-KB complex
as its binding partners. TNF-ct is a multifunctional cytokine, which participates in a wide
variety of biological activities such as cell proliferation, differentiation, apoptosis, lipid
metabolism, and coagulation. Knock-out studies in mice have suggested a neuroprotective
function for this cytokine.
Both of pfetin's binding partners are involved in cell signal transduction regulating the
cell cycle (e.g., proliferation, differentiation). They are also functionally connected in the
TNF-ct/NF-KB pathway. In fact, this pathway is initiated by the binding of TNF-c to its
receptors TNFRSF 1A and TNFRSF lB at the cell surface, requiring many protein complexes
to implement the intracellular signal cascade which eventually leads to activation of the NF-
KB complex and its targeted genes (Bouwmeester et al. 2004). Knock-out mice studies from
both TNF-a and TNFRSFlB have suggested neuroprotective function (Bruce et al. 1996).
Inappropriate activation of NF-KB has been associated with a number of inflammatory
diseases while persistent inhibition of NF-KB leads to inappropriate immune cell development
or delayed cell growth (Ghosh 2002).
Immunoprecipitation identified a number of candidate binding partners for pfetin.
Some proteins ubiquitously expressed in the cell were most likely immunoprecipitated as part
of the experimental background noise (e.g., heat shock and heat shock related proteins).
However, two of pfetin's binding candidates also showed ties to the TNF-ct/ NF-KB pathway.
PHB2 (prohibitin 2) (aliases: REA, p22, Bap37, BCAP37, PNAS-141) is a novel histone
deacetylase-associated protein that functions putatively as a mediator of transcription (Kurtev
et al. 2004). It also interacts with RelA, another pfetin interactor, and plays a part in the TNF-
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a trigged signaling cascade of activation of NF-KB (Bouwmeester et al. 2004). The other
pfetin interactor CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and
dihydroorotase) is a multifunctional protein that initiates and regulates mammalian de novo
pyrimidine biosynthesis (Sigoillot et al. 2005). CAD also interacts with TRADD
(TNFRSF 1 A-associated via death domain adaptor protein) which in turn interacts with one of
TNF-a's major receptors, TNFRSF1A, and mediates programmed cell death signaling and
NF-KB activation (Sandu et al. 2005).
The TNF-a/NF-KB pathway is an elaborate pathway that forms the basis for numerous
physiological and pathological processes involving a network of 680 non-redundant proteins
(Bouwmeester et al. 2004). Interactions of pfetin with many members of the TNF-a/NF-KB
pathway suggest possible involvement in cellular processes inducible via TNF-a. However,
the exact manner in which pfetin interacts and functions with members of this complex
signalling cascade awaits further investigation.
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Figure 1. Expression of Pfet]/Kctd12 in Affymetrix Mouse Genome 430 Array. The left column is
a heat map showing the hierarchical clustering of 38 probe sets that reveal a similar expression
pattern as Pfet//Ketd]2. Each probe set is presented by one row along the Y axis and the samples
(mouse developmental stages from embryonic day (E) 10.5 to post-natal day (P)12 are presented in
duplicate on the top along the X axis from left to right. The expression level of each probe set is
standardized against itself across different developmental stages and is shown in color spectrum
from red (high) to blue (low). The column on the right lists the genes associated with each probe
set.
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Figure 2. Network graph of 38 cluster genes from Affymetrix Chip analysis. Genes or gene products are
represented as nodes, and the biological relationship between two nodes is represented as an edge (line).
Filled in nodes represent members of the 38 gene cluster. GenelProtein IDs marked with an asterisk
indicate that multiple identifiers from the input list mapped to a single gene in the Global Molecular
Network.
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CHAPTER 5
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SUMMARY
The cochlea is a complex organ comprised of dozens of cell types and specialized
regions required for the normal process of hearing. Of the genes responsible for hearing and
deafness, many of the encoded proteins have been shown to be expressed in the cochlea with
a variety of functions including transcription factors, potassium ion channels, gap junctions,
and extracellular matrix components. As a part of the continuing effort in finding genes
important for hearing and deafness, a novel cochlear transcript with a predominantly fetal
expression containing a single tetramerization domain (PFET1, HUGO-approved symbol
KCTD12) was identified from the Morton fetal cochlea cDNA library. This thesis reports
characterization of this novel human gene and its encoded protein pfetin in relation to its role
in auditory function.
KCTDI2 was selected through subtractive hybridization and differential screening of
humnan fetal cochlear cDNA clones. KCTD12/Kctdl2 is an evolutionarily conserved intronless
gene encoding a 6 kb transcript in human and three transcripts of approximately 4, 4.5 and 6
kb in mouse. The protein, pfetin, is predicted to contain a voltage-gated potassium channel
tetramerization (T 1) domain. Expression of KCTD12/Kctdl2 or its encoded protein pfetin was
characterized in several species including human, monkey, mice, guinea pig, and zebrafish.
Of particular interest are the time course and regions of expression in the inner ear. Initial
findings demonstrated a striking preferential expression of the human 6 kb transcript in a
variety of second trimester human fetal tissues (including brain and cochlea) with
dramatically lower expression levels in adult tissues. GeneChip analysis also revealed
developmental upregulation of expression of Kctdl2 in the mouse utricle along with a cluster
of 38 other genes between stages E13.5 and P6. Real Time RT-PCR substantiated
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upregulation of right on and leftover (ron and ov: KCTD12 zebrafish orthologs) during the
first 24 hours post fertilization (hpf) of embryo development. Immunohistochemistry with a
polyclonal antibody raised against a synthetic peptide to the KCTD12 sequence revealed
immunostaining in a variety of cell types in human, monkey, mouse, and guinea pig cochleas
(notably types I, IV and V fibrocytes and spiral ganglion cells) and the vestibular system,
including type I vestibular hair cells (Chapter 2). Mouse developmental
immunohistochlemical analysis demonstrated a dramatic increase in the expression of pfetin in
postnatal cochlea. Both in sitt hybridization with a ron riboprobe and immunohistochemistry
with a Ron antibody revealed expression of the pfetin zebrafish ortholog in the vestibular-
cochlear ganglion (VCG) of the developing zebrafish otic vesicle (Chapter 3).
These observed expression patterns strongly suggest a developmental role for
KCTD12 and its encoded protein. Most of the upregulation in RNA expression was seen
spanning or overlapping crucial inner ear developmental milestones. The emergence of otic
placode (mouse E8.5, zebrafish 13-14 hpf), the formation of otic vesicles (mouse E9.5,
zebrafish -18.5 hpf), the initiation of auditory hair cells differentiation (mouse E14, zebrafish
24 hpf), and hair cell transduction (mouse El6, zebrafish 36 hpf) all occur during the first 36
hours post zebrafish embryo fertilization and first 16 to 17 days post observation of a vaginal
plug in the mouse. Similarly by 20-22 weeks gestational age, the human fetus developed a
functional ear to detect sound in its surroundings. Both zebrafish and mouse RNA expression
persisted after these inner ear developmental milestones had occurred. There was down-
regulation of Kctdl2 in mouse utricle after P6 and of ron expression in the zebrafish after 72
hpf. However, there was never any complete secession of expression, at least into early
adulthood. In mouse, expression persisted until 12 months (Chapter 2, Fig. 6B) and zebrafish
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until after 6 days post fertilization (dpf) (Chapter 3, Fig. 2). In humans, data are not available
for KCTD12 expression during young adulthood. By late adulthood, the 6 kb KCTD12
transcript has disappeared from various regions of adult brain (Chapter 2, Fig. 5B) perhaps as
the result of the ageing process.
Given the expression level from various Northern blot analyses and RT-QPCR
experiments, it is difficult to extrapolate from the overall expression level of the whole
embryo and whole brain to the expression near the auditory sense organ. Sections from
zebrafish in sitlu hybridization provided one of the confirmations of KCTD12/ron expression
in the developing auditory sense organ (Chapter 3, Fig. 4). Immunohistochemical analysis
provided additional evidence in support of the importance of the KCTD12-encoded protein
pfetin in the developing auditory sense organ with immunostaining signals observed from
Ron (pfetin zebrafish ortholog) labeling vestibular-cochlear ganglion (VCG), and
immunostaining signals detected from various cells within the mouse cochlea.
Immunohistochemical analysis of the human fetal cochlea was inconclusive due to technical
issues arising from the fixation of available tissue for study. The common fixative used to
preserve fetal tissue can interfere with the binding of antibody to its antigen. Therefore, it is
not clear when pfetin begins to be expressed in early human cochlear development.
The developmental protein expression from mouse and zebrafish did not follow the
exact time course as that of RNA expression. This is not unusual given the fact that the
relationship between RNA and protein expression for many genes is not necessarily well
correlated. In fact, the commencement of mouse and zebrafish protein expression lagged
behind their respective peak RNA expression and after most of the key inner ear
developmental milestones have passed. In zebrafish, protein expression in the VCG region
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commenced around 24 hpf and persisted well after 75 hpf (data not shown). In mouse,
protein expression in the cochlea commenced postnatally (Appendix to Chapter 2) and then
continued well into adulthood (Chapter 2, Fig. 8B). This protein expression time course
suggests that perhaps pfetin/Ron might be necessary for the continuing growth and health of
the inner ear.
Morpholino experiments further revealed the potential importance of the presence of
Ron in the developing VCG by demonstrating a correlation between Ron knock-down and
lsll (early inner ear neuronal marker) down-regulation in the VCG during early zebrafish
development. Isll has been postulated to cooperate with NeuroD in the confirmation of inner
ear-specific neuronal or sensory competency/identities (Radde-Gallwitz et al. 2004).
Therefore, pfetin/Ron could potentially function as an important regulator in the development
of inner ear neurons.
The genomic location for KCTD12 was confirmed by FISH analysis to band q21 on
chromosome 13 which presently maps within the vicinity of the AUNAI locus (13ql4-21)
responsible for progressive autosomal dominant auditory neuropathy (Kim et al. 2004). There
are no known deafness loci mapped in close proximity to the KCTD12 mouse ortholog,
Kctdl2, on chromosome 14 or the zebrafish ortholog right on on linkage group 1. No
pathogenetic sequence variants were detected within the 70% GC-rich KCTD12 ORF from
mutation analysis of a panel of DNAs from individuals from multiplex kindreds without a
recognized genetic etiology for their hearing loss. Although much has been learned about
KCTD12 and its encoded protein pfetin through this thesis research, much remains to be
known. The discovery and characterization of each new gene expressed in the ear takes us
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ever closer to attaining a more complete understanding of this intricate and wonderful life-
enhancing process that is human hearing.
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Appendix to Chapter 2:
Isolation from Cochlea of a Novel Human Intronless Gene with Predominant Fetal Expression
Mouse Developmental Immunohistochemistry
Materials and Methods
Tissue preparation and immunohistochemical staining procedures were performed as
previously described (Resendes et al., 2004). ICR mice were crossed to produce embryos.
The day the vaginal plug was found was identified as E.5. Cochleas from mouse
developmental ages embryonic stages 13.5 and 17.5, and postnatal day 1 and 10 were
collected for this study. Primary anti-PFET1 antibody was diluted between 1:200 and 1:500.
Reslit/Discussion
Similar to the expression pattern observed in adult mouse cochlea in postnatal days 1
and 10 mouse cochlear sections, immunostained cells included various fibrocytes
(predominately types I and IV) in the spiral ligament, limbal fibrocytes and supralimbal and
interdental cells in the limbus, and spiral ganglion cells. Unlike the adult cochlear expression,
immunostaining was observed in almost all cell types within the cochlea at postnatal day 1.
Immunostaining of individual cell types became distinguishable by postnatal day 10.
However, no pfetin immunostained cells were observed in embryonic mouse cochlea.
Although Northern blot analysis revealed early Kctdl2 expression in developing embryonic
mouse whole brain and embryo tissues, it is well known that the relationship between RNA
and protein expression for many genes is not necessarily well correlated, and appears to be the
situation observed here for Kctd]2. Immunohistochemical analysis of developing mouse
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cochlea indicated a dramatic up-regulation of the expression of pfetin during transition from
the embryonic to postnatal stage. Such tightly regulated yet widely distributed expression of
pfetin in mouse cochlea during the early postnatal stage lends further support to the
importance of Kctdl2 during cochlear development.
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Figure Caption.
Pfetin inununostaining of developmental mouse cochleas EI7.5, PI and PI0. Developing
E17.5 mouse cochlea is shown at the top. Higher magnification of the boxed region for E17.5
is shown to its right labeled as EI7.5m. Higher magnification of the boxed regions for PI are
shown in the center labeled as PIA m and PIB m (m for magnification). The arrows in PI
point to immunostained acoustic ganglions in the developing modiolus. Arrows in PI0 point
to inununostained types I and IV fibrocytes (left up and down) and limbal fibrocytes (right).
Higher magnification of the boxed region for PI OB is shown to the right labeled as PI OBm.
All scale bars represent 25J.1m,except for PIA which is 250J.1m. E = embryonic, P= postnatal
122
